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1.1 The genus Hypericum 
The genus Hypericum, Hypericaceae family, previously classified as 
Guttiferae or Clusiaceae (Stevens 2007), shares with all the others genera 
of the family peculiar characteristics: entire opposite leaves, polypetalous 
corolla, stamens grouped in bundles, seeds without endosperm and 
presence of glandular secretions. It includes about 450 species of trees 
(e.g. H. bequaertii), bushes and herbs spread all over the temperate areas 
of the World. The genus is not present in extremely dry, hot or cold  
habitats.  The name of the genus Hypericum probably originates from the 
two Greek words: Hyper = over and eikon = image, which indicates that 
plants of this genus were believed to ward off evil or bad luck. The 
genus Hypericum includes about 450 species of flowering plants and 
represents approximately 80% of the diversity of the family 
Hypericaceae. The most known and investigated species of the genus is 
Hypericum perforatum which is a medicinal plant used by the popular 
medicine since centuries.   
1.1a  Hypericum perforatum 
Hypericum perforatum (Fig.1) is a completely glabrous herbaceus plant 
species, characterized by a stem lignified at the base, opposite shortly 
petiolate or entire lanceolate sessile leaves, yellow flowers made of  5 
embricated sepals usually grouped in a terminal cyme; numerous stamens 
free or united at the base into three or five bundles; 3-5 styles; superior 
and ovoidal ovary; fruits represented by septicid capsule;  cylindric and 
numerous seeds with reduced or absent endosperm (Bombardelli-
Morazzoni, 1995). The leaves are yellow-green in color, with transparent 
dots throughout the tissue with a few black dots on the lower surface.  
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Leaves exhibit obvious translucent dots when held up to the light, giving 
them a „perforated‟ appearance, hence the plant's Latin name. 
There are morphologic, geographic and cytologic evidences indicating 
that H. perforatum originated from hybridization of  two strongly 
correlated species. One of these is the H. maculatum subsp. immaculatum 
(2n=16), which is diffused in Western Europe and in Siberia and 
morphologically similar to the H. perforatum; the other species seems to 
be the  H. attenuatum (2n=16), which is diffused from the Siberia to 
Korea and China and shows the morphological characteristic of H. 
perforatum missing in H. maculatum. The hybridization area seems to be 
the Siberia  (Crockett and Robson,  2011). 
H. perforatum shows a strong intraspecific variability impossible to 
classify. According to the Flora of Italy by Pignatti (1982), three different 
varieties or subspecies are considered: the subspecies perforatum, 
characterized by the distribution of black nodules on the leaf border; the 
subspecies veronense characterized by dark lines on the stem and the 
subspecies angustifolium,  rare, with linear lanceolate leaves of  3-7 x 12-25 
mm. The anatomic peculiarity of Hypericum perforatum is the presence on 
leaves, stem and flowers of both translucent glands and black globules, 
secretory structures storing pharmacologically active compounds.  
The translucent glands are distributed all over the leaf lamina and they 
accumulate essential oils (Mathis and Ourrison, 1963), while the dark 
globules are generally localized on the stem, on the leaf and flower  
border and on the anthers and they contain hypericin and its derivatives 
(Baroni Fornasiero et al.,1998). 
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Fig. 1 A, Hypericum perforatum ; B, morphological characteristics of the species: Ba, flower 
with numerous stamens, Bb, capsules, Bc, seeds, Bd, stem with black globules, Be, leaves 
showing translucent glands and black nodules on the margins, Bf, black globule 
containing red coloured hypericin. 
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1.2 Use, Pharmacological Activity and Clinical properties  
The use of H. perforatum L., commonly known as St. John's wort, has a 
long tradition in the folk medicine of the Occidental culture. From the 
time of the ancient Greeks down through the Middle Ages, the plant was 
believed to possess magical powers and was used to ward off evil and 
protect against disease. As a practical folk-remedy, it has been widely 
used for the treatment of cold, chest congestion, menstrual cramps, 
wounds, burns, snake bites, asthma, tuberculosis, skin problems, kidney 
troubles and to alleviate nervous disorders. 
Nowadays H. perforatum is considered a medicinal plant of great interest 
mainly used in the treatment of mild to moderate  depression. H. 
perforatum based products are commercially available as tablets, capsules, 
oils, spray, tea and tincture form. All the preparations are available as 
aqueous-alcoholic extracts and oil extracts.  The two types of 
preparations differ for the chemical composition and the therapeutic 
indication. The major active constituents of the aqueous-alcoholic 
extracts are phloroglucinols (hyperforins) and flavonoids, together with 
lesser amounts of hypericins and traces of xanthones and 
proanthocyanins. This type of preparation is used orally for the 
treatment of neurological disorders (mild to moderate depression, 
anxiety, restlessness, nervous tension, migraine, headache), to argue 
rheumatism, gout and as antidiarrheal and diuretic agents; or topically for 
the treatment of bites, bruises, wounds and swellings. The major active 
constituents of the oil extracts are phloroglucinols, flavonoids and 
essential oils. This type of preparation is used orally for treating gastric 
 6 
 
disorders, bacterial infections, mouth and throat pain; or topically in the 
treatment of wounds and burns (McCutcheon, 2002).   
1.3 Phytochemical profile of Hypericum perforatum 
H. perforatum contains several classes of bioactive compounds. The first 
phytochemical studies on H. perforatum dates back on 1830, when 
Buchner discovered and isolated the “Red Hypericum” from the plant. 
Nowadays H. perforatum represents the most investigated species among 
the  medicinal plants, because of its documented antidepressive, 
antitumoral and antimicrobial activities. The most important bioactive 
compounds of H. perforatum can be grouped in 8 classes: 
 Phenylpropans detected as derivatives of esters of 
hydroxycinnamic acids as the p-coumaric acid, the caffeic acid 
and the chlorogenic acid (Fig.2).   
 Flavonoids and flavonoid glucosides: The flavonoid 
glucosides having quercetin as aglycone  represent the main 
group (2-4 %)  in H. perforatum. Generally in the extracts it‟s 
possible to detect only a small amount of free quercetin (Fig.2) 
and this can be maybe due to the hydrolysis of the glucosides 
during the extraction process. Hyperoside and rutin are generally 
the major compounds, followed by the isoquercetin and the 
quercetrin (Fig.2). Kaempferol is not always detected in the 
extract.  
 Biflavons: the  I3,II8-biapigenin and the amentoflavon are the 
only detected compounds belonging to this group and found 
exclusively in the buds and in the blooms.  
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 Tannins and proanthocyanidins: the presence of condensed 
tannins was demonstrated as early as 1925 by Podoko and 
described in detail in the following decades. The 
proanthocyanidins represent 12% of the dry weight (Melzer et 
al., 1991). The mixture of proanthocyanidins contains only 
derivatives of catechin and epicatechin of (dimers, trimers and 
polymers of high molecular weight).  
 Naphtodianthrones: The emodin anthrone is the precursor of 
hypericins (Lavie et al. 1995). Pseudohypericin is the main 
naphtodianthrone generally present in concentration 2 or 4 
times higher than hypericin (Fig.2). Among the subspecies of  
H. perforatum,  H. perforatum subsp. angustifolium was found to be 
the richer in hypericin (Males et al., 2006). Hypericin is 
accumulated in the black globules, which are present in all the 
aerial parts of the plant (flowers, capsules, leaves, stems), but not 
in the roots.  
 Phloroglucinols: The hyperforin (Fig.2) and adhyperforin are 
the main compounds belonging to this class and found in  H. 
perforatum. Both the products are accumulated in the 
reproductive structures (flowers and fruits) (Soelberg et al., 
2007). Chatterijee et al. (1998) suggested that hyperforins are the 
major compounds involved in the antidepressive activity.  
 Xanthones: xantones are phenolic compounds deriving from 
the benzoic acids metabolism (Fig.2). This class of molecules is 
better described in section 1.5. 
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 Essential oils: leaves and flowers of  H. perforatum are 
characterized by the presence of schizogenous secretory 
structures containing essential oils. Monoterpens α-pinene and 
β-pinene, myrcen and limonene and some sesquiterpens are 
typical costituents of the oil.  
1.4 Plant type III Polyketide Synthases (PKSs III) 
The plant type III Polyketide Synthases are a class of enzymes catalyzing 
the formation of very important natural products exhibiting a wide 
variety of bioactivities such as: antibiotic, anticancer, antifungal, 
immunosuppressant and insecticides (Fig.3). PKSs III are homodimeric 
proteins with two independent active sites which catalyze a series of 
decarboxylation, condensation and cyclization reactions to generate 
polyketides of different lengths. The PKSs III utilize two substrates: a 
CoA-linked starter unit (usually aromatic CoA) and an acetyl unit 
(derived from malonyl-CoA) to form an intermediate linear product. 
Once formed, the linear polyketide is cyclized in the same active site 
cavity to form the final product (Jez et al., 2001). In a phylogenetic tree, 
the PKSs from angiosperms fall into two clusters. One cluster comprises 
chalcone synthase (CHS) and the other cluster contains the functionally 
divergent enzymes including biphenyl synthase (BIS) and benzophenone 
synthase (BPS), but also many different CHS-like proteins. The two 
groups originate from an ancient duplication of an ancestral gene. 
  
 9 
 
 
A                                                                                B                                                                                                    
 
                                                                               
 
 
 
 
 
 
 
 
 
 
C                                                                                  D 
 
 
 
 
E                                                                                  F 
 
Fig. 2: A, chlorogenic acid; B, quercetin; C, quercetrin; D, hypericin; E, hyperforin; F, 
paxanthone. 
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1.4.a Type III PKSs and polyketide metabolites in H. perforatum 
Analyzing the active components of H.perforatum extracts, it is possible to 
detect the activity of at least four different PKSs: CHS, BPS, 
isobutyrophenone synthase (BUS) and octaketide synthase (OKS). 
CHS  provides the first committed step in flavonoid biosynthesis by 
catalyzing the sequential decarboxylative addition of three acetate units 
from malonyl-CoA to a p-coumaroyl-CoA starter molecule derived from 
phenylalanine via the general phenylpropanoid pathway. 
BUS stepwise condenses one unit of isobutyril-CoA with three units of 
malonyl-CoA to give the  phlorisobutyrophenone which which is the 
precursor of hyperforin. OKS is suggested to condensate one acetyl-
CoA with seven malonyl-CoA to form an octaketide chain that 
subsequently undergoes cyclizations and decarboxylation to form 
emodin anthrone, precursor of the hypericin. BPS catalyzed the 
condensation of one unit of benzoyl-CoA with three molecules of 
malonyl-CoA to form a linear tetraketide intermediate which undergoes 
Claisen condensation to form the phlorbenzophenone (Liu et al., 2003). 
Phlorbenzophenone is the precursor of many important bioactive 
compounds. When it undergoes regioselective ring closures by a 
cytochrome P450, it is converted in xanthones. 
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Fig.3 Type III Polyketide Synthases catalyzing the formation of very important 
secondary metabolites. BIS, Biphenyl Synthase; BPS, Benzophenone Synthase; CHS, 
Chalcone Synthase; STS, Stilbene Synthase.  
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1.5 Xanthones  
Xanthones are heterocyclic compounds having a dibenzo-γ-pyrone 
skeleton as basic structure. The name xanthones designates a group of 
secondary metabolites normally found in a restricted assembly of higher 
plants (mainly belonging to the families of Hypericaceae and 
Gentianaceae) fungi and lichens.  
1.5.a Xanthone biosynthesis  
The biosynthesis of xanthones was studied for the first time in cell 
cultures of Centaurium erythraea and then in cell cultures of Hypericum 
androsaemum L. These two systems showed two alternative pathways for 
xanthone biosynthesis.  BPS from C. erythraea catalyses the condensation 
of one molecule of 3-hydroxybenzoyl-CoA with three molecules of 
malonyl-CoA to form the 2,3‟,4,6-tetrahydroxybenzophenone, which is 
then converted in 1,3,5-trihydroxyxanthone by a xanthone synthase  
(Beerhues, 1996).  
BPS from H. androsaemum prefers benzoyl-CoA as starter substrate and 
catalyses the stepwise condensation of three molecules of malonyl-CoA 
with one molecule of benzoyl-CoA to form the 2,4,6-
trihydroxybenzophenone, which is then converted in 2,3‟,4,6-
tetrahydroxybenzophenone by a benzophenone 3‟-hydroxylase. The 
2,3‟,4,6-tetrahydroxybenzophenone is then converted in a variety in a 
variety of important prenylated plant metabolites (Fig.4) and in  1,3,7-
trihydroxyxanthone (Schmidt et al., 1997). 
Both 1,3,5- and 1,3,7-trihydroxyxanthones are precursors of higher plant 
xanthones, thus the 2,3‟,4,6-tetrahydroxybenzophenone represents a 
crucial point for xanthone biosynthesis. 
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Analyzing the two alternative pathways described above, it emerges that 
the conversion of benzophenone in xanthones is dependent on the 3-
hydroxy group. That‟s why, when benzoylCoA acts as substrate, 3-
hydroxylation occurs at the benzophenone level (Beerhues, 1996). 
 
Fig.4 2,3‟,4,6-tetrahydroxybenzophenone is converted in a variety of important 
metabolites and in 1,3,5- and 1,3,7-trihydroxyxanthone, the precursors of all the other 
xanthones.  
 
1.5.b Biological activities of xanthones 
One of the undisputed function of the phenolic compounds is their role 
in protecting plants against microbial invasions. That‟s why it is possible 
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to find them as constitutive compounds or as inducible defense in 
response to microbial attack (phytoalexins). Xanthones have been 
detected as constitutive compounds, but studies investigating their 
inducibility as phytoalexins in vivo are missing, while many in vitro studies 
suggest their role in the inducible response to microbial attacks. Cell 
cultures represent an important system to investigate the regulation of 
secondary metabolite biosynthetic pathways. When treated with 
pathogens or with pathogen derived substances, it is possible to induce a 
defense response in plant cells and detect the activation or inhibition of 
biosynthetic pathways. Regarding xanthones, Beerhues and Berger 
(1995) observed an increase in xanthone accumulation in cell cultures of 
Centaurium  erythraea  upon elicitation with yeast extract and methyl 
jasmonate (Meja). Conceicao et al. (2006) and Tocci et al. (2010) 
reported the increase in xanthone production from H. perforatum cell 
cultures after Colletotrichum gloeosporioides cell wall extracts, MeJa, salicylic 
acid and chitosan elicitation. Franklin et al. (2009) studying xanthone 
production in response to Agrobaterium tumefaciens  elicitation in  H. 
perforatum cell cultures suggested a double role of xanthones in the 
defense response as antioxidant and antimicrobial compounds (Fig.5). 
After the inoculation of A. tumefaciens in the cell culture a rapid 
upregulation of the gene encoding for BPS and the de novo production of 
xanthones were observed.  The authors measured the antioxidant and 
antimicrobial activity of the extracts from elicited cells and they 
suggested that in vivo xanthones on one hand constitute a powerful 
antioxidant system of protecting the host cells from self-generated 
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reactive oxigen species (ROS) and on the other hand have also the 
potential to act as phytoalexins against the pathogen.  
 
Fig. 5 Proposed role of xanthones in plant defense (Franklin et al., 2009). 
 
1.5.c Pharmacological activities of xanthones 
Their role in the plants explains the increased interest in the chemistry of 
xanthones for the prospect to treat human diseases caused by pathogenic 
microorganism.  
Among the documented pharmacological and biological activities of 
xanthones: 
 Antifungal, antibacterial, antiviral activities: prenylated 
xanthones have been documented the most for their 
antimicrobial activity. In order to understand their mechanism 
of action, some prenylated xanthones have been tested against 
Bacillus subtilis, Staphilococcus aureus and Micrococcus luteus. Data 
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collected during these studies suggest that isoprenoid substituted 
xanthones may exert antimicrobial action by reducing the 
fluidity of outer and inner layers of bacterial cell membranes 
(Toshio et al., 2004). Not only prenylated xanthones are  
reported as antimicrobial agents but also some simple 
oxygenated xanthones and some xantholignoids (Fotie and 
Bohle, 2006). 
With respect to antifungal profile of tested xanthones, it seems to be 
dependent on the hydroxyl group on ring A and B. This finding is 
supported by studies carried out testing mangostin against plant 
pathogenic fungi Fusarium oxysporum vasinfectum, Alternaria tenuis and 
Dreschlera oryzae. The alkylation of C-3 and C-6 hydroxyl groups resulted 
in the considerably reduction of the antifungal activity, and replacement 
with alkyl groups of increasing chain length correlates with decreasing 
inhibitory activity (Gopalakrishnan et al.1997) Prenylated xanthones are 
not the only xanthones reported for their antimicrobial activity. Some 
simple oxygenated xanthones and some xantholignoids have proved to 
be great antimicrobial agents (Fotie and Bohle, 2006). 
 Antimalarial activity: hydroxyxanthones have been identified 
as novel antimalarial agents. The malaria parasite has a limited 
capacity for de novo synthesis of aminoacids and its survival is 
dependent on hemoglobin proteolysis. The products of  
hemoglobin proteolysis  are amino acids and heme. The amino 
acids are incorporated by the parasite and heme oxides to 
hematin. Free hematin can damage the cellular metabolism 
inhibiting enzymes involved in the surveillance of cell integrity. 
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Plasmodial species lack the heme oxygenase involved in the 
heme catabolism. To protect from heme, Plasmodium sequesters 
the product into a inner crystal (hemozoin). Hydroxyxanthones 
are believed to exert their activity by complexation of the heme 
group and inhibition of hemozoin crystal formation. This 
process is able to induce the death of the parasite as a 
consequence of the toxicity of the free hematin (Fotie and 
Bohle, 2006).  
 Anti-inflammatory activity: some hydroxyxanthones have 
been shown to exert anti-inflammatory activity by inhibiting the 
expression of cell adhesion molecules (CAM), which are 
responsible of the recruitment of leukocytes to the site of 
inflammation (Madan et al., 2004). 
 Antioxidant activity: many phenolic compounds, including 
xanthones, have been shown to act as scavengers of various 
oxidizing species. Among xanthones, prenylated xanthones are 
the most widely reported for their antioxidant activity (Fotie and 
Bohle, 2006). 
 Enzyme inhibitory activity: different xanthones have been 
found to be able to inhibit the action of very important enzymes 
involved in human pathologies. A very important activity is 
inhibition of monoaminooxidase (MAO). 1,6-
dihydroxyxanthone and 1,3,6-trihydroxyxanthone exhibited 
potent inhibitory activity toward MAO, an enzyme which plays 
an important role in the regulation of some neurologically active 
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amines (Ohishi et al, 2000). The inhibitors of MAO are useful in 
the therapy of psychosis, depression and schizophrenia.   
 Vascular activity: xanthones and xanthone derivatives have 
been shown to have beneficial effects on some cardiovascular 
diseases like ischemic heart disease, atherosclerosis, 
hypertension and thrombosis (Jiang et al., 2004). Their beneficial 
effects are due to the antioxidant, anti-inflammatory, anti-
platelet and antithrombic activities.  
1.5.d Xanthones in H. perforatum 
Table 1 shows the list of xanthones reported for the species H. 
perforatum. Chemical analysis revealed that xanthones are accumulated 
mostly in the roots, but studies to individualize cells, tissues or organs  
responsible of their synthesis are missing. The investigation of biological 
properties of xanthones from H. perforatum revealed an interesting 
antifungal activity against plant pathogenic fungi belonging to the genera 
Phomopsis and Colletotrichum (Crockett el a., 2010). Unfortunately 
xanthones are present in H. perforatum extracts only in traces, not 
exploitable for applicative uses.  
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Tab. 1 Xanthones in H. perforatum plants 
Xanthones 
Aerial 
parts 
Roots References 
Mangiferin  X  
Kitanov & Nedialkov 1998  
 
Kielcorin   X 
Nielsen & Arends 1978; 
Crockett et al 2010, Tocci et 
al., Unpublished  
1,3,6,7-tetrahydroxyxanthone   X 
Sparenberg et al., 1993; 
Tocci et al., Unpublished  
1,3,5-trihydroxyxanthone   X 
Murunganandam et al., 2000  
 
1-hydroxy-3,5-
dimetoxyxanthone  
 X 
Murunganandam et al., 2000  
 
1,3,5-trihydroxyxanthone   X 
Murunganandam et al., 2000; 
Tocci et al., Unpublished  
Paxanthone   X 
Tocci et al. Unpublished  
 
1,3,5,6-tetrahydroxyxanthone   X 
Tocci et al. Unpublished  
 
5-O-methyl-2-
deprenylrheediaxanthone B  
 X 
Crockett et al 2010; Tocci et 
al. Unpublished  
1,7-dihydroxyxanthone   X 
Tocci et al. Unpublished  
 
4,6-dihydroxy-2,3-
dimetoxyxanthone  
 X 
Crockett et al 2010  
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1.6 Biotechnology advances for the production of xanthones in 
Hypericum perforatum 
The plant kingdom has historically been a major source of bioactive 
compounds for medicine, food additives, pigments, insecticides, 
cosmetics, and fine chemicals. However, the recovery of bioactive 
compounds from natural sources is often problematic,  in that the 
extract may contain only very small quantities or its composition may 
vary with the season or the environment. To obtain qualitatively and 
quantitatively standardized extracts, plant biotechnology can represent a 
valuable alternative. The advantages of this technology over the 
conventional agricultural production are as follows:  
 It is independent of geographical and seasonal variations and 
various environmental factors.  
 It offers a defined production system, which ensures the 
continuous supply of products, uniform quality and yield. 
 It is possible to produce novel compounds that are not normally 
found in parent plant. 
 Efficient downstream recovery and product. 
 Rapidity of production. 
 Plant cell can perform stereo- and regiospecific 
biotransformations for the production of novel compounds 
from cheap precursors. 
For these reasons in the decades many studies have been focalized on 
plant cell cultures as a possible method to produce plant secondary 
metabolites of commercial interest (Verpoorte et al., 1993, 1998; 
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Buitelaar and Tramper,1992; Lipsky, 1992; Su, 1995). However, for many 
of the desired compounds,  the production from cell cultures  is too low. 
This is usually because some compounds require tissue differentiation to 
be correctly synthesized.  
Many authors demonstrated that in undifferentiated calli and suspended 
cells of H. perforatum xanthones are the main metabolic products 
accumulated (Dias et al., 1999; Dias et al., 2001; Pasqua et al., 2003; 
Conceicao et al., 2006). Cell cultures of H. perforatum have been shown to 
synthesize mainly xanthones characterized by a 1,3,5,6- and/or a 1,3,6,7- 
oxygenation pattern and that their production is highly influenced by 
hormone supplementation  (Dias et al., 2001). In particular Dias et al. 
(2001) and Tocci et al. (2010) observed a positive linear relationship 
between naphthalene acetic acid concentration in the culture medium 
and xanthone accumulation. Moreover Mulinacci et al. (2008) showed 
that also for H. perforatum subsp. angustifolium xanthones are the main 
metabolites produced in calli and suspended cells. However all of the 
studies mentioned above reported the production of only small amount 
of xanthones not exploitable for applicative purposes.  
The elicitation is a technique commonly used in plant biotechnology to 
enhance secondary metabolite production and it has been applied to 
suspended cell cultures of H. perforatum.  Conceicao et al. (2006) found a 
substantial increase in xanthone production after treatment of H. 
perforatum cell cultures both with methyl jasmonate and Colletotrichum 
gloeosporioides, which is a natural fungal pathogen of the species. The same 
founding was observed by Franklin et al. (2008) and Tocci et al. (2010) 
when using respectively A. tumefaciens and chitosan as elicitors. However 
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even if elicitation has represented a step forward for the enhancement of 
xanthone production from cell cultures of H. perforatum, their amount 
was still far away from what is necessary for applicative uses. 
For  the production of medicinally important compounds, organ cultures 
represents a valid alternative being relatively more stable (Roja, 1994). By 
transformation with Agrobacterium rhizogenes,  the so called “hairy roots", 
can be obtained. Hairy roots can grow without plant growth hormones, 
and are good producers of the typical root secondary metabolites, but 
their induction requires the use of selectable markers, often resistence 
genes, and this has raised question for human health. With respect of 
this point of view, the adventitious root cultures are a promising reliable 
way for production of pharmaceutically and nutraceutically important 
metabolites. Moreover many efforts have been made to induce hairy 
roots production from H. perforatum explants (Vinterhaltern et al., 2006; 
Franklin et al., 2008), but the poor results obtained suggest that the 
species is recalcitrant to the transformation with A. rhizogenes. 
1.6.a Adventitious root cultures  
Adventitious roots have been successfully induced in many plant species 
(Table 2) and cultured for the production of high value secondary 
metabolites of pharmaceutical, nutraceutical and industrial importance. 
Although root cultures of H. perforatum have also been established by 
other authors (Goel et al. 2009; Cui et al. 2010;   Tocci et al., 2011), the 
capacity of these cultures to produce xanthones has never been explored.  
The production of secondary metabolites from adventitious roots 
involves four stages (Fig.6). The first stage is the induction of 
adventitious roots from plant explants. The induction can be direct from 
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many type of explants (roots, rhizome, leaves, stem) or indirect  
involving callus formation and re-differentiation in roots. Both direct 
and indirect rhizogenesis are achieved by exposure of plant tissues to 
various concentrations of auxins like indol-3-acetic acid, indole-3-butyric 
acid, naphthaleneacetic acid or 2,4-dichlorophenoxyacetic acid, which are 
able to induce both growth of pre-existing roots (e.g. stimulating 
branching) or adventitious root formation. 
When roots are formed, the second stage is the cultivation in liquid 
medium in flasks or small bioreactors. This phase includes the 
optimization of growth kinetics of adventitious roots and the evaluation 
of secondary metabolite accumulation. The third stage is the 
development of strategies to enhance metabolite production. The 
secondary metabolism can be stimulated by elicitors, which are signals 
triggering the activation of  biosynthetic pathways for secondary 
metabolites.  The use of biotic and abiotic elicitors reduce the process 
time to attain high product concentrations (Ramachandra et al 2002). 
The stress signaling molecules like methyl jasmonate or salicylic acid, or 
molecules of fungal, bacterial and yeast origins (chitosan, glycoproteins, 
polysaccharides) and salts of heavy metals are frequently used with 
success in elicitation experiments. Once biomass and secondary 
metabolism parameters have been optimized, the fourth stage is the 
scale-up process of the cultures in a bioreactor. 
Regarding adventitious roots, due to their structural features and 
metabolite localization characteristics, they need different type of 
reactors than the ones used for plant cell cultures.  The main problem in 
bioreactor is the tendency of roots to form clumps. Moreover it is 
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impossible to define one best bioreactor type because the rheological 
properties vary from one species to another. 
 
Tab.2 Cultures of adventitious roots for the production of important 
metabolites 
 
 
 
 
 
Plant species  Metabolites  Importance  References  
Anthemis nobilis  Geranyl isovalerate  
Essential oil, fragrance, 
anti-inflammatory  
Omoto et al., 1998  
Cornus capitata  Tannins  Antioxidant  Tanaka et al., 2001  
Duboisia 
myoporoides,   
 D. leichhardtii 
hybrid  
Scopolamine, 
hyoscyamine  
Spamolytic, kydriatic 
agents  
Yoshimatsu et al., 
2004  
Echinacea 
purpurea, E. 
angustifolia  
Caffeic acid 
derivatives  
Immunostimulant, Anti-
inflammatory, anti-
oxidant  
Wu et al., 2006  
Iris germanica  
Irigenin, 
Iristectorigenin A 
(Flavonoids)  
Anti-inflammatory, anti-
cancer  
Akashi et al., 2005  
Scopolia 
parviflora  
Hyoacyamine 
(Alkaloid)  
Anticholinergic  
Kang et al. 2004, 
Min et al., 2007  
Panax ginseng  
Ginsenosides 
(Saponins)  
Immunostimulant, Anti-
inflammatory,anti-
oxidant, anti-cancer, anti-
fatigue  
Choi et al., 2000; 
Kim 2002;  Kim  
et al., 2005;  Jeong 
et al., 2006; Son  
et al., 1999  
Panax 
notoginseng  
Saponins  
Immuntostimulant, anti-
cancer  
Gao et al., 2005  
Raphanus 
staivsus  
Anthocyanin  Food coloring  
Betsui et al., 
2004  
Rhus javanica  
Galloylglucoses,  
riccionidin A  
Anti-oxidants  
Taniguchi et al., 
2000  
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The choice of the bioreactor has to be done independently for each 
species considering all the parameters that could affect the productivity 
of the system. The downstream process for the recovery of metabolites 
represents the final step of the production system. The process should 
be as simple as possible. The metabolites of interest can be released in 
the culture medium or accumulated by the organ. The first case is the 
most desirable and convenient for the recovery of metabolites and for 
the conservation of root biomass, allowing a continues culture without 
loss of plant material. At the end of culture period, in fact, the liquid 
medium is collected and processed for the extraction of metabolites, 
while the biomass is ready for a new productive cycle.  In the second 
case,  the release of metabolites can be stimulated by wide variety of 
permeabilizing agents, such as organic solvents (isopropanol, 
dimethylsulfoxyde) or by the help of other permeabilization methods, 
including ultrasonication, electroporation and ionophoretic release. 
When these tools don‟t work, it is necessary to collect and process the 
biomass, resulting in loss of part of it.  At the end of a culture period, 
part of the biomass is transferred to new medium to start a new 
productive cycle, while part is destroyed for metabolite recovery. All the 
stages described above represent a bottle-neck to be considered in the 
evaluation of cost/benefit advantages for production of secondary 
metabolites from root cultures at industrial levels. (Murthy et al., 2008). 
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  Fig.6 Steps involved in the development and establishment of adventitious root 
cultures.  
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Aims of the research project 
 Xanthones are secondary metabolites showing many biological 
activities. Hypericum perforatum is a medicinal plant intensively studied 
for its curative properties. In spite of this, little is known about 
xanthone biosyntheisis in the species. The aim of the present 
research project has been to investigate xanthone biosynthesis in 
planta and in in vitro systems of Hypericum perforatum subsp. 
angustifolium at chemical and molecular levels. Moreover, organ and 
tissue localization, through whole mount in situ hybridization, of the 
gene transcript of benzophenone synthase, key enzyme of xanthone 
biosynthesis, have been carried out both in plantlets and in in vitro 
roots.  
In parallel, a biotechnological system for xanthone production at 
exploitable levels from root cultures has been established and optimized 
using different elicitors such as chitosan and derivatives. Root extracts 
and isolated xanthones  have been tested in antifungal therapy against 
human pathogenic fungi. The objectives have been pursued as follows: 
1. Xanthone biosynthesis and accumulation in tissues and 
organs. 
The study has been carried out through: 
 To individuate xanthone accumulation organs chemical 
analysis were carried out both in plants grown-wild and 
grown under controlled conditions; 
 To individuate tissues and organs responsible for xanthone 
biosynthesis, cloning, functional charcaterization and localization of 
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benzophenone synthase (key enzyme of xanthone biosynthesis) gene 
transcript, through whole mount in situ hybridization, have been 
carried out both in plantlets and in vitro roots. 
2. Establishment of  root cultures for xanthone production at 
exploitable levels for applicative purposes. 
The study has been carried out through: 
 Establishment of root cultures;  
 Evaluation of regenerated roots capability to produce 
xanthones; 
 Optimization of culture conditions to increase biomass and 
xanthone yields; 
 Optimization of xanthone production by elicitation with 
chitosan and its derivatives. 
 
3. Evaluation of antifungal activity of xanthone-rich extracts 
against human pathogenic fungi. 
The tests have been carried out through: 
 Determination of the Minimum Inhibition 
Concentration (MIC) at which the xanthone-rich extracts 
are able to inhibit the growth of human fungal pathogens 
(Candida spp., dermatophytes and Cryptococcus neoformans). 
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Abstract 
The medicinal properties of the aerial parts of Hypericum perforatum subsp 
angustifolium have been extensively investigated, yet little is known about 
the chemical composition or potential uses of the root extracts. In the 
present study, xanthone production in plants grown wild in different 
areas and in plantlets grown under controlled conditions was 
investigated. Chemical analyses performed on wild grown plants revealed 
that xanthones were mainly accumulated in the roots. We detected 1,7-
dihydroxyxanthone, 1,3,5,6-tetrahydroxyxanthone and paxanthone (the 
first report of these xanthones in this species), together with 5-O-
methyl-2deprenylrheediaxanthone B, kielcorin and 1,3,6,7-
tetrahydroxyxanthone. Wild grown plants showed variability and a low 
yield in xanthone content in the roots. Compared to the roots of wild 
grown plants, the roots of plantlets grown under controlled conditions 
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had a 27-times greater xanthone accumulation. Moreover, they produced 
toxyloxanthone B, which was not detected in the roots from wild plants; 
kielcorin was not detected. Since xanthones are known for their 
antifungal activity, the extracts from both samples were tested against the 
human fungal pathogens as Candida albicans, Candida spp., dermatophytes 
and Cryptococcus neoformans. The root extracts from plantlets grown under 
controlled conditions showed greater antifungal activity. In conclusion, 
the roots of plants grown under controlled conditions have greater 
antifungal activity, especially against Candida species, and this activity is 
positively correlated with xanthone accumulation. 
 
Key words: Hypericum, roots, Candida, dermatophytes, Cryptococus, 
antifungal. 
 
Introduction 
Hypericum perforatum L. (Hypericaceae) is a medicinal plant which is 
distributed throughout Eurasia (Cervo et al., 2002). The medicinal 
properties of the aerial parts of H. perforatum have been extensively 
investigated, and several classes of secondary metabolites have been 
identified, including naphthodianthrones (i.e., hypericin and 
pseudohypericin), flavonol glycosides (i.e., isoquercitrin and hyperosid), 
biflavonoids (i.e., amentoflavone), and phloroglucinol derivatives (i.e., 
hyperforin and adhyperforin) traces of xanthones have also been found 
(Nahrstedt and Butterweck 2010). The interest in H. perforatum has been 
mainly focused on its antidepressant effects. Although the medicinal 
properties of the aerial parts have been extensively investigated, little is 
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known about the chemical composition or the potential applications of 
the root extracts. Recently, Crockett et al., (2011) isolated three 
xanthones from root extracts of H. perforatum: 1,6-dihydroxy-5-methoxy-
4′,5′-dihydro-4′,4′,5′-trimethylfurano-(2′,3′:3,4)-xanthone; 4,6-dihydroxy-
2,3-dimethoxyxanthone; and cis-kielcorin; and they evaluated their 
antifungal activity against plant pathogenic fungi. Tocci et al. (2011 and 
2012) demonstrated that extracts from in vitro regenerated roots of H. 
perforatum subsp. angustifolium, treated with chitosan, showed antifungal 
activity against human fungal pathogens, in particular, Candida species, 
Cryptococcus neoformans and dermatophytes. They also found a positive 
correlation between xanthone accumulation and antifungal activity 
(Tocci et al., 2012). The importance of these results lies in the fact that, 
in the past 30 years, there has been a dramatic increase in the incidence 
of fungal infections (Pfaller et al., 2010) and in the number of pathogenic 
fungi that are resistant to commercial antifungal compounds; 
consequently, there has been a greater need for effective therapy (De 
Vita et al., 2012), which has led to the search for therapeutic alternatives 
among natural products (Oliveira et al., 2012). 
The objective of the present study was to evaluate the chemical 
composition and antifungal activity of root extracts obtained from H. 
perforatum subsp. angustifolium plants, and to compare these characteristics 
between plants grown wild at different altitudes and in different soil 
conditions with plants grown in vitro under controlled conditions.  
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Materials and methods 
Plant material 
Wild grown plants of H. perforatum subsp. angustifolium were collected at 
the vegetative stage in two areas outside of Rome, Italy (i.e., Tivoli 
Terme and Poli). The plants were collected at two different altitudes 
[68m and 453m above sea level (asl), respectively, in Tivoli Terme and 
Poli] and in different types of soil (calcareous in Tivoli Terme and 
volcanic in Poli). To obtain plants grown under controlled conditions, 
seeds of H. perforatum subsp. angustifolium were collected from Tivoli 
Terme; they were surface sterilized in accordance with Zobayed et al. 
(2004) and then inoculated in flasks containing 100 ml of half strength 
Murashige and Skoog (MS) (1962) medium (Duchefa Biochemie, 
Haarlem, the Netherlands) supplemented with 1.5% (w/v) sucrose. The 
cultures were grown under a photoperiod of 16/8 h (light/dark) at 26°C 
(photon lux density, 70 μmol m−2 s−1).  
Extraction and chemical analysis 
The roots and aerial parts of the wild grown plants and the roots of two-
month-old in vitro plantlets were separated and dried at room 
temperature for 48h until they reached constant weight. All of the 
solvents used for extraction were purchased from Carlo Erba Reagents, 
Italy. Each sample consisted of an aliquot of 4 g (DW), which was 
ground and subjected to three extractions of 24 h with methanol at room 
temperature under dark conditions. The obtained extracts were 
evaporated with a rotary evaporator and dissolved in methanol (HPLC 
grade) for chemical analysis. The HPLC apparatus consisted of a high 
pressure pump (Waters 1525) and a dual wavelength UV detector (Dual 
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λ Detector Waters 2487), equipped with a C18 column 4.6x150 mm, pore 
size 5 μm (Waters). The chromatographic separation was performed 
through a gradient elution consisting of 2.5 % acetic acid in Milli-Q pure 
water (solution A) and methanol (solution B), according to the method 
proposed by Dias et al. (1999) with small modifications. Rutin, 
isoquercetrin and hyperosid were analysed according to the method 
(method 2) proposed by Kartig et al. (1996), by isocratic elution with a 
solution of acetonitrile, water and phosphoric acid (16:83:1). The flow 
rate was kept at 1 ml/min, and metabolites were detected at 260 nm and 
320 nm based on UV spectra of flavonoids and xanthones. The 
identification of the peaks was carried out by the internal standard 
method. Standard compounds for xanthones (1,3,6,7-, 1,3,5,6,-
tetrahydroxyxanthone; 1,7-dihydroxyxanthone;  kielcorin;  paxanthone 
and 5-O-methyl-2-deprenylrheediaxanthone B) and flavonoids 
(chlorogenic acid, quercetrin, quercetin, luteolin, rutin, and isoquercetrin) 
were kindly provided by Dr. Franco Ferrari. Hyperosid was purchased 
from Extrasynthese (Geney, France). The concentration of metabolites 
in the extracts was calculated using calibration curves realized by 
injecting standards at different known concentrations. Xanthones were 
quantified as paxanthone-equivalents. For the chemical analysis, the 
arithmetic mean and standard deviation (SD) of compound 
concentration (di che cosa?) were calculated. 
Organisms 
For the antifungal evaluation, we tested strains obtained from the 
American Type Culture Collection (ATCC, Rockville, MD, USA), the 
German Collection of Microorganisms (DSMZ, Braunschweig, 
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Germany) and the Pharmaceutical Microbiology Culture Collection 
(PMC, Department of Public Health and Infectious Diseases, “Sapienza” 
University, Rome, Italy). The strains were: Candida albicans (ATCC 10231, 
ATCC 10261, ATCC 3153, ATCC 24433, ATCC 90028, PMC 1011, 
PMC 1002, and PMC 1010), non-albicans Candida species (C. parapsilosis 
ATCC 22019, C. parapsilosis DSM 11224, C. tropicalis DSM 11953, C. 
tropicalis  PMC 0908, C. tropicalis PMC 0910, C. glabrata PMC 0805, C. 
krusei DSM 6128, and C. krusei PMC 0613), Cryptococcus neoformans (DSM 
11959, PMC 2136, PMC 2123, PMC 2115, PMC 2103, PMC 2107, PMC 
2102, and PMC 2111), dermatophytes (Trichophyton mentagrophytes DSM 
4870, T. mentagrophytes PMC 6503, T. mentagrophytes PMC 6509, T. 
mentagrophytes PMC 6531, T. mentagrophytes PMC 6515, T. mentagrophytes 
PMC 6552, Microsporum gypseum PMC 7331, and M. gypseum PMC 7303). 
All of the strains were stored and grown in accordance with the 
procedures of the Clinical and Laboratory Standards Institute (CLSI) 
(CLSI, 2008a, b). 
Antifungal susceptibility assays 
In vitro antifungal susceptibility was evaluated for both the total root 
extracts from the wild grown plants and the two-month-old in vitro 
plantlets, using the CLSI broth microdilution methods  (CLSI, 2008a, b). 
The antifungal reference fluconazole (Sigma-Aldrich, St. Louis, Missouri, 
U.S.A.) was also tested. The final concentration ranged from 0.0625 to 
128 µg mL-1 for fluconazole and from 1 to 1024 µg mL-1 for total dry 
root extracts. The extracts were dissolved previously in dimethyl 
sulfoxide at concentrations 100 times higher than the highest desired test 
concentration and successively diluted in test medium in accordance with 
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the procedures of the CLSI (CLSI, 2008c). Microdilution trays 
containing 100 µL of serial two-fold dilutions of root extracts in RPMI 
1640 medium (Sigma-Aldrich, St. Louis, Missouri, U.S.A) were 
inoculated with an organism suspension adjusted to attain a final 
inoculum concentration of 1.0 x 103 - 1.5 x103 cells mL-1 for yeasts and 
0.4x104 - 5x104 CFU mL-1 for dermatophytes. The panels were incubated 
at 35°C and observed for the presence of growth at 48 h (Candida spp.) 
and 72 h (C. neoformans and dermatophytes). 
The minimal inhibitory concentration (MIC) was defined as, for yeasts, 
the lowest concentration that showed ≥50% growth inhibition 
compared with the growth control and, for dermatophytes, the lowest 
concentration that showed ≥80% growth inhibition compared with the 
control. The results are expressed as the geometric mean and range of 
the MIC.  
 
Fig. 1: (A) HPLC chromatogram of the extract of aerial parts of H. perforatum grown wild 
in Tivoli Terme and analyzed using method 1: 1, chlorogenic acid; 2, quercetrin; 3, 
quercetin; 4, luteolin; (B) HPLC chromatogram of the same extract analyzed using 
method 2 to resolve the peak at RT 16 min: 5, rutin; 6, hyperoside; and 7, isoquercetrin. 
The double lines in each chromatogram correspond to the wavelengths 280 nm and 320 
nm. 
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Results  
Chemical analysis of the extract of the aerial parts 
The chemical analysis of the extracts from the aerial parts of H. 
perforatum subsp. angustifolium plants collected in Tivoli Terme (Figure 1) 
and Poli revealed the presence of phenolic compounds (mainly 
flavonoids and phenolic acids), however, we found none of the 
xanthones for which reference compounds were available. The 
comparison of retention time (RT) and the co-injection with standards 
led to the identification of chlorogenic acid, quercetrin, quercetin, 
luteolin, rutin, hyperosid and isoquercetrin. The identified metabolites 
were quantified according to the compound-specific calibration curves; 
the concentrations are reported in Table 1 with small differences in the 
amount of hyperosid (16.562 ± 0.605 mg/g DW in the extract from 
plants collected in Tivoli Terme and 10.28+ 0.65 mg/g DW in the 
extract from the plants collected in Poli) and quercetin (0.24+0.022 
mg/g DW for Tivoli and 0.85+ 0.031 mg/g DW for Poli). . 
Chemical analysis of the extract of the roots 
 HPLC analysis revealed that, differently from the aerial parts, the roots 
of wild plants contained many xanthones (Figure 2), namely, 1,3,6,7-, 
1,3,5,6,-tetrahydroxyxanthone; 1,7-dihydroxyxanthone;  kielcorin;  
paxanthone and 5-O-methyl-2-deprenylrheediaxanthone B, together with 
vanillic acid and luteolin (Table 1). The total amount of xanthones was 
2.4 times higher in the sample collected in Tivoli Terme (427.27 + 26.21 
µg/g DW), compared to that collected in Poli (179+20.21 µg/g DW). In 
the extract from Tivoli Terme, kielcorin and paxanthone were the main 
xanthones (172.53+11 µg/g DW and 170.74+12.6 µg/g DW, 
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respectively), whereas the main xanthone in the extract from Poli was 5-
O-methyl-2-deprenylrheediaxanthone B (104+12µg/g DW). 
 
 
Fig. 2 HPLC chromatogram of root extracts from H. perforatum wild grown plants in 
Tivoli Terme (black) and collected from in vitro plantlets (grey). 1, vanillic acid; 5, luteolin; 
X1, 1,3,4,6-, 1,3,6,7-tetrahydroxyxanthone; X2, kielcorin; X3, 1,7-dihydroxyxanthone; 
X4, toxyloxanthone B; X5, paxanthone; X6, 5-O-methyl-2-deprenylrheediaxanthone B. 
The chromatrograms are detected at 280 nm wavelengths (The chromatrograms were 
performed at a wavelength of 280 nm.  
 
Chemical analysis of the extract of the roots from in vitro-germinated plantlets 
The roots from the two-month-old plantlets, which had been obtained 
by seeds collected in Tivoli Terme and grown under controlled 
conditions, contained 27 times more xanthone than the roots from the 
wild grown plants (11.65 ± 0.93 mg/g DW and 0.43 + 0.03 µg/g DW, 
respectively). Moreover, the xanthone profiles (Figure 2) also differed: 
toxyloxanthone B was found, yet there were no traces of kielcorin (Table 
1). 
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Table 1: Chemical analysis of root extracts obtained from in field-collected plants and 
grown under controlled conditions.  
Compound  
TivoliAPif* PoliAPif* TivoliRif* PoliRif* Riv* 
 
(mg/g DW) 
      
Chlorogenic acid 1.5 + 0.071 1.44+ 0.062 nd nd Nd 
Vanillic Acid nd nd 0.002. ±0.002 nd Traces 
Quercetin 0.24 + 0.022 0.85+ 0.031 nd nd Nd 
Quercetrin 1.612 + 0.064 1.21+ 0.071 nd nd Nd 
Luteolin 0.036 + 0.002 0.021+ 0.004 Traces 0.025+ 0.002 Traces 
Hyperosid 16.562 + 0.605 10.28+ 0.65 nd nd Nd 
Rutin 0.334 + 0.013 0.142+ 0.035 nd nd Nd 
Isoquercetin 4.851 + 0.212 3.33+ 0.048 nd nd Nd 
1,3,5,6-; 1,3,6,7-
tetrahydroxyxanthone 
nd nd Traces Traces 2.712±0.121 
Kielcorin nd nd 0.173+ 0.011 0.036+ 0.006 Nd 
1,7-dihydroxanthones nd nd 0.011 + 0.005 0.039+ 0.002 2.121±0.082 
Toxyloxanthone B nd nd 0.073 + 0.003 nd 1.312±0.051 
Paxanthone  nd nd 0.171+ 0.013 nd 2.143±0.072 
5-O-methyl-2-
deprenylrheediaxanthone 
B 
nd nd Traces  0.104+ 0.012 3.274±0.154 
*Aif, aerial parts from in field-grown plants; Rif, roots from in field-grown plants; Riv, 
roots from plants grown under controlled conditions.  nd=not detected. 
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Antifungal activity 
The antifungal activity of total root extracts from the wild grown plants 
and the two-month-old in vitro plantlets against Candida albicans, non-
albicans Candida species, C. neoformans, and dermatophytes was evaluated 
(Table 2). The extract from the wild grown plant roots showed moderate 
antifungal activity against all of the tested fungi, with a geometric mean 
MIC of 663.98 µl/ml for C. albicans, 512 µl/ml for non-albicans Candida 
species, 215 µl/ml for dermatophytes and 53.81 µl/ml for C. neoformans. 
The extract from the roots of the plantlets grown in vitro showed greater 
antifungal that the extract from the root of wild grown plants, which is 
consisted with the higher amount of xanthones in the former. In 
particular, this extract showed greater antifungal activity against C. 
albicans, non albicans Candida species and dermatophytes, with a geometric 
mean of 73.94, 57.02, and 114 µl/ml, respectively; the antifungal activity 
against Cryptococcus neoformans was not greater than that found for the 
extract from wild grown roots. 
 
Discussion 
We evaluated the chemical profile of H. perforatum subsp angustifolium 
plants grown in the wild in different areas and grown under controlled 
conditions, and we investigated the pattern of xanthone accumulation 
and the antifungal activity of extracts containing xanthones. The interest 
in xanthones as new therapeutic agents lies in their documented 
microbiological activities (Fotie and Bohle, 2006). Pasqua et al. (2003) 
demonstrated that in H. perforatum in vitro systems, xanthones were 
accumulated in the roots regenerated from plantlets or formed by callus, 
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yet they were not found in the aerial parts. According to the literature, 
only traces of mangiferin have been found in the aerial parts of wild 
grown plants (Kitanov and Nedialkov, 1998). 
 
Table 2: Antifungal activity against human fungal pathogen of root extracts obtained 
from in field-collected plants and grown under controlled conditions.  
* Rif, roots from in field-grown plants; Riv, roots from plants grown under controlled 
conditions. **Geometric mean of the minimal inhibitory concentration (MIC). Strains: 
Candida albicans (ATCC10231; ATCC10261; ATCC3153; ATCC24433; ATCC90028; 
PMC 1011; PMC1002; PMC1010) Candida species no albicans (C .parapsilosis 
ATCC22019; C. parapsilosis DSM11224; C. tropicalis DSM11953; C tropicalis  
PMC0908, C. tropicalis PMC0910; C. glabrata PMC0805; C. krusei DSM6128, C. krusei 
PMC0613), Cryptococcus neoformans ( DSM 11959, PMC2136, PMC2123, PMC2115, 
PMC2103, PMC2107, PMC2102, PMC2111),  T. mentagrophytes DSM 4870, PMC6503, 
PMC6509, PMC6331, PMC6515, PMC6552; M. gypseum PMC7331, PMC7303). 
 
In the present study, no xanthones were detected in the aerial parts of 
the plants collected in either of the areas. In the root extracts of wild 
plants, the xanthones 1,7-dihydroxyxanthone, 5-O-methyl-
2deprenylrheediaxanthone B, kielcorin, paxanthone, 1,3,5,6-
Fungal strain  
TivoliRif* Riv* Fluconazole 
GM ** (µg/mL) 
RANGE 
(µg/mL) 
GM ** 
 (µg/mL) 
RANGE 
(µg/mL) 
GM** (µg/mL) 
RANGE 
(µg/mL) 
Candida albicans 663.98 256-1024 73.94 32-128 1.3 0.25-16 
Candida species  512 64-1024 57.02 16-128 2.31 0.5-64 
Cryptococcus neoformans 53.81 32-128 53.82 32-64 2.06 0.5-4 
dermatophytes 215.27 64-1024 114.03 32-1024 8 1-32 
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tetrahydroxyxanthone, and 1,3,6,7-tetrahydroxyxanthone were found. 
With regard to 1,7-dihydroxyxanthone, 1,3,5,6-tetrahydroxyxanthone 
and paxanthone, to the best of our knowledge this is the first report of 
these xanthones in the roots of wild grown H. perforatum plants. In the 
roots collected in Tivoli Terme, kielcorin and paxanthone were the major 
xanthones, followed by 1,7-dihydroxyxanthone, whereas the 1,3,5,6- and 
1,3,6,7-tetrahydroxyxanthones were only present in traces. By contrast, 
the major xanthone in the roots collected in Poli was 5-O-methyl-2-
deprenylrheediaxanthone B, and only traces of paxanthone were. 
Although the total amount of xanthones detected was quite low (0.43± 
0.03 and 0.18±0.02 mg/g DW in Tivoli Terme and Poli respectively), 
most of them have been found to have antimicrobial activity. 5-O-
methyl-2-deprenylrheediaxanthone B has been shown to possess 
antifungal activity against species of the genus Phomopsis (Crockett el al., 
2011). 1,7-dihydroxyxanthone and the 1,3,5,6- and 1,3,6,7-
tetrahydroxyxanthones show antimicrobial activity against Candida spp 
strains (Fotie and Bohle, 2006). The differences found when comparing 
the wild grown plants in the two areas could be attributed to 
environmental factors such as, soil composition, and  altitude. In light of 
the variability in metabolite content observed in the plants collected in 
different localities (Conforti et al., 2012), we investigated roots from 
plantlets grown under controlled conditions. Compared to the roots 
from the wild grown plants, those from the in vitro plantlets had a 
xanthone content that was 27 times greater; the roots from the plants 
also contained toxyloxanthone B, which was not found in the roots of 
wild grown plants, yet they did not contain kielcorin. A comparison of 
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antifungal activity of H. perforatum roots from wild grown plants and 
from plantlets grown under controlled conditions is reported for the first 
time in this study against C. albicans, non albicans Candida species, C. 
neoformans, and dermatophytes. The geometric mean MIC for the root 
extracts from the in vitro plantlets, compared to the MIC for the root 
extracts from the wild grown plants, was 9 times lower for C. albicans, 9 
times lower for the non-albicans Candida species, and 2 times lower for 
dermatophytes.  In conclusion, the roots of plants grown under 
controlled conditions have greater antifungal activity, especially against 
Candida spp, and this activity is positively correlated with xanthone 
accumulation. A future prospective study will include different species of 
Hypericum grown under controlled conditions, with the objective of 
identifying the species with the best antifungal activity. 
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Annex 1 
 HPLC Methods  
 
Table 1: Method 1*, gradient elution 
Time (minutes) Solution A (%) Solution B (%) 
1 90 10 
2 70 30 
8 60 40 
13 50 50 
15 50 50 
23 30 70 
28 30 70 
38 20 80 
50 20 80 
55 5 95 
65 5 95 
70 10 90 
*The method is a modification of the one reported by Dias et al. 1999. 
 
Table 2: Method 2*, isocratic elution  
Acetonitrile (%) Water (%) 
Phosphoroic 
acid (%) 
16 83 1 
*Kartig et al. (1996) 
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Annex 2 
Standard compounds 
 
 
Fig.1 HPLC chromatogram of standard compounds: 1, chlorogenic acid; 2, 
vanillic acid; 3 quercetrin; 4, quercetin; 5, luteolin; 6, kampferol.   
 
Fig.2 HPLC chromatogram of standard compounds: 7, rutin; 8, hyperoside; 9, 
isoquercetrin. 
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Fig.3 HPLC chromatogram of xanthone reference compounds: X1, 1,3,6,7-, 
1,3,5,6,- tetrahydroxyxanthone mix; X2, kielcorin; X3, 1,7-dihydroxyxanthone; 
X4,paxanthone; X5, 5-O-methyl-2-deprenylrheediaxanthone B 
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Annex 3 
Calibration curves  
 
 
Fig.1 Calibration curves for standards compounds used to quantitatively analyze 
the extract composition. 
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Chapter 4: 
 
From the plant to in vitro cultures 
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The chemical analysis performed on wild grown H. perforatum plants 
demonstrated that roots are the accumulation organ of xanthones. 
However the detected amount was very low and sensitive to 
environmental factors. These limitations lead to the establishment of 
cultures of plants grown under controlled conditions to investigate the 
potential of H.perforatum root extracts for applicative purposes. The 
extract from roots of plants grown under controlled conditions 
accumulated higher amounts of xanthones and the antifungal activity 
was improved.  
It is known that root cultures are a good system to produce secondary 
metabolites. In the light of the data obtained from in vivo plants, roots 
have been regenerated from callus of Hpa and cultures have been 
established and analyzed to detect xanthone accumulation. 
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Chapter 5: 
Root cultures of Hypericum perforatum subsp. 
angustifolium elicited with chitosan and production 
of xanthone-rich extracts with antifungal activity 
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Abstract 
Hypericum perforatum is a well known medicinal plant which contains a 
wide variety of metabolites, including xanthones, which have a wide 
range of biological properties, including antifungal activity. In the 
present study, we evaluated the capability of roots regenerated from calli 
of Hypericum perforatum subsp. angustifolium to produce xanthones. Root 
biomass was positively correlated with the indole-3-butyric acid 
concentration, whereas a concentration of 1 mg l-1 was the most suitable 
for development of roots. High auxin concentrations also inhibited 
xanthone accumulation. Xanthones were produced in large amounts, 
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with a very stable trend throughout the culture period. When the roots 
were treated with chitosan, the xanthone content dramatically increased, 
peaking after 7 days. Chitosan also induced a release of these metabolites 
into the culture. The maximum accumulation (14.26 ± 0.62 mg g-1 dry 
weight) and release (2.64±0.13 mg g-1 dry weight) of xanthones were 
recorded 7 days after treatment. The most represented xanthones were 
isolated, purified and spectroscopically characterized. Antifungal activity 
of the total root extracts was tested against a broad panel of human 
fungal pathogen strains (30 Candida species, 12 Cryptococcus neoformans, and 
16 dermatophytes); this activity significantly increased when using 
chitosan. Extracts obtained after 7 days of chitosan treatment showed 
high antifungal activity (mean MIC 83.4 µg ml-1, of 39.1 µg ml-1, and 114 
µg ml-1, against, respectively, Candida spp, C. neoformans, and 
dermatophytes). Our results suggest that root cultures can be considered 
as a potential tool for large-scale production of extracts with stable 
quantities of xanthones. 
 
Keywords Hypericum perforatum, root cultures, xanthones, Candida spp., 
Cryptococcus neoformans, dermatophytes  
 
Introduction 
The pharmacological properties of Hypericum perforatum are well known. 
It contains a wide variety of metabolites with documented biological 
activities, including phenolic acids, flavonoids, naphthodianthrones, 
phloroglucinols and xanthones (Nahrstedt and Butterweck 2010). In a 
preliminary study on naturally grown plants of H. perforatum subsp. 
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angustifolium (HPA) (unpublished), we found that xanthones were mainly 
produced in the roots, though in very low quantities, whereas flavonoids, 
naphtodianthrones and phloroglucinols were distributed in the aerial 
parts of the plant. 
Xanthones have a wide range of biological and pharmacological 
properties, such as monoamine oxidase inhibition, and antioxidant, 
antimicrobial, cytotoxic, and hepatoprotective activity (Fotie and Bohle 
2006). The antifungal activity of many xanthones has also been well 
documented (Lavault et al. 2005; Wang et al. 2005; Pinto et al. 2011). 
This reflects the renewed interest in plant extracts with antifungal 
activities, which has been due to the increasing number of 
immunocompromised persons (e.g., organ transplant recipients, 
chemotherapy patients, and persons with AIDS), and the consequent 
sharp increase in the frequency of fungal infections (Pfaller and  
Diekema, 2010). This in turn has led to an increase in the prescription of 
antifungal drugs and the emergence of drug resistance. In light of these 
circumstances and considering that there is only a limited arsenal of 
antifungal drugs and agents, new therapeutic approaches must be 
developed (Rapp 2004; Pfaller et al. 2010). Although the antifungal 
activity of xanthones from a number of Hypericum species against human 
pathogenic fungi has been investigated (Fenner et al. 2005; Radulovic et 
al. 2007), little is known about the possible application of xanthones 
from H.  perforatum roots. 
The plant kingdom has historically been a major source of bioactive 
compounds for medicine, food additives, pigments, insecticides, 
cosmetics, and fine chemicals. However, the recovery of bioactive 
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compounds from natural sources is often problematic, in that the extract 
may contain only very small quantities or its composition may vary with 
the season or the environment. To obtain qualitatively and quantitatively 
standardized extracts, plant biotechnology can represent a valuable 
alternative. 
In the present study, we evaluated the capability of regenerated roots 
from calli of HPA to produce xanthones, which has never been 
investigated. To increase xanthone production, we used chitosan, an 
effective biotic elicitor for improving xanthone biosynthesis in cell 
cultures of HPA (Tocci et al. 2010). We also tested the antifungal activity 
of total extracts and of the most representative xanthones against a 
broad panel of human fungal pathogens. 
Materials and methods 
Plant material and tissue culture  
Seeds of HPA were surface sterilized in accordance with Zobayed et al. 
(2004) and placed on Murashige and Skoog (MS) (1962) medium 
(Duchefa Biochemie, Netherlands) supplemented with 3% (w/v) sucrose 
and solidified with agar. Seed cultures were grown under a photoperiod 
of 16/8 h (light/dark) at 26°C (photon lux density 70 µmol m-2 s-1). To 
induce the regeneration of adventitious roots, leaf and stem explants 
were excised from 2-month-old seedlings and placed on solid MS 
medium supplemented with 5 mg l-1, 2,4-dichlorophenoxyacetic acid 
(2,4-D) (Duchefa Biochemie, Netherlands), 1 mg l-1 kinetin (Duchefa 
Biochemie, Netherlands), and 3% (w/v) sucrose; the cultures were 
maintained under continuous darkness. After 28 days of culture, the 
callus were transferred to hormone-free (HF) agarized MS medium, to 
 69 
 
induce the formation of roots. Regenerated roots, 2-3 cm in length, were 
isolated from the callus (after 30 days) and subcultured in the same 
medium. To induce branching (lateral root formation) and to increase 
biomass, the roots (after 30 days) were cultured in MS medium 
supplemented with different concentrations of indole-3-butyric acid 
(IBA) (0, 0.5, 1, 1.5 and 2 mg l-1). Liquid cultures were established after 
30 days, by inoculating 0.02 g dry weight (DW) of roots in 250 ml 
Erlenmeyer flasks containing 100 ml half-strength liquid MS medium 
supplemented with 1 mg l-1 IBA. The flasks were shaken at 100 rpm at 
25±1 C° and maintained in the dark. Subcultures in liquid medium were 
performed every 23 days. 
Elicitation 
Xanthones were elicited using chitosan (medium molecular weight, 
Sigma-Aldrich, Italy) at a final concentration of 200 mg l-1, which was 
added on the 8th day of culture. Root samples were harvested by 
filtration on the 11th, 15th, 18th and 23rd days of culture. 
Determination of root biomass 
The biomass was determined by recording the DW of the roots. The 
roots were separated from the medium by passing them through a 
stainless steel sieve and washed with distilled water to remove medium 
contaminants. They were then dried in an oven at 40°C for 72 hours, 
and the DW was measured. The growth index was calculated as follows: 
 
 
 
 
 weightdried Initial
 weightdried Initial- weightdried Final
IndexGrowth 
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HPLC analysis 
Ground-dried roots (4-6 months in culture) were extracted three times 
with methanol, at room temperature. The culture media were extracted 
with ethyl acetate using a separating funnel. The final volume of the 
extracts was dried with a rotavapor and subjected to HPLC. The HPLC 
analysis of the extracts was performed using an apparatus consisting of a 
pump (Waters 1525 Binary HPLC Pump), equipped with a UV detector 
(Waters 2487 Dual λ Detector) and a reverse phase C18 column (4.6 mm 
X 150 mm; 5 µm; Waters). The extract composition was determined by 
linear gradient elution, using a modified version of the method of Dias et 
al. (1999). The mobile phase was a gradient prepared from 100:0.1 (v/v) 
water–phosphoric acid (component A) and methanol (component B) 
(Carlo Erba, Milan, Italy); the gradient program was from 10% to 50% B 
in 13 min, hold for 10 min, and then from 50% to 95% B in 42 min. The 
injection volume was 20 μl, the mobile phase flow rate was 1.0 ml min-1. 
The compounds were identified at 260 nm and 320 nm by the external 
standard method, using, as reference, xanthones that had been 
previously purified and spectroscopically characterized in our laboratory 
(1,3,6,7-tetrahydroxyxanthone, 1,3,5,6-tetrahydroxyxanthone, 
toxyloxanthone B, paxanthone, and cadensin G). 1,7-dihydroxyxanthone 
and 5-methoxy-2-deprenylrheediaxanthone B were purified from in vitro 
regenerated roots of HPA. Xanthones were quantified as paxanthone 
equivalents at 260 nm. 
Purification and 1H-NMR analysis of xanthones 
The isolation and purification of 1,7-dihydroxyxanthone and 5-methoxy-
2-deprenylrheediaxanthone B were carried out by preparative thin layer 
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chromatography (silica gel, hexane:ethyl acetate 2/1) (Carlo Erba, Milan, 
Italy). The nuclear magnetic resonance spectroscopic data were recorded 
at room temperature on an Avance 400MHz NMR Spectrometer. The 
NMR chemical shifts (δ) are expressed as parts per million (ppm) relative 
to the residual proton chemical shifts of the deuterated solvent (acetone-
D6) set relative to external tetramethylsilan (TMS). 
1,7-dihydroxyxanthone (euxanthone): 1H-NMR (400 MHz, AcD6): δ 
12.72 (1H, s, OH–C1), 7.72 (1H, t, J= 8.0 Hz, H-3), 7.63 (1H, d, J= 2.8 
Hz, H-8), 7.54 (1H, d, J= 9.2 Hz, H-5), 7.45 (1H, dd, J= 9.2 and 2.8 Hz, 
H-6), 7.02 (1H, d, J= 8.0 Hz, H-4), 6.78 (1H, d, J= 8 Hz, H-2).  
5-methoxy-2-deprenylrheediaxanthone: B 1H-NMR (400 MHz, AcD6) δ: 
13.40 (OH-1, s ), 7.85 (H-8, d, J = 8.7 Hz),  7.03 (H-7, d, J = 8.7 Hz), 
6.18 (H-2, s), 4.60 (H-2‟, q, J = 6.6 Hz), 4.02 (OMe, s), 1.65 (4‟-CH3 , s), 
1.43 (3‟-CH3, d, J= 6.6 Hz), 1.35 (5‟- CH3, s).   
Organisms 
For the antifungal evaluation, strains obtained from the American Type 
Culture Collection (ATCC, Rockville, MD, USA), from the German 
Collection of Microorganisms (DSMZ, Braunschweig, Germany) and 
from the Pharmaceutical Microbiology culture collection (PMC, 
Department of Public Health and Infectious Diseases, Sapienza, Rome, 
Italy) were tested. The strains obtained from the ATCC were: Candida 
albicans ATCC90028, C. albicans ATCC90029, C. albicans ATCC10261, C. 
albicans ATCC10231, C. albicans ATCC3153, C. albicans ATCC2091, C. 
albicans ATCC76615, C. albicans ATCC24433 (tested as reference strain), 
Candida parapsilosis ATCC22019 (tested as quality control strain), and 
Trichophyton mentagrophytes ATCC9972 (tested as reference strain). The 
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strains obtained from the DSMZ were: C. parapsilosis DSM11224, C. 
parapsilosis DSM5784, Candida krusei DSM6128, Candida tropicalis 
DSM11953, Candida glabrata DSM11226, Cryptococcus neoformans 
DSM11959, C. neoformans DSM6972, T. mentagrophytes DSM4870, 
Trichophyton rubrum DSM4167, Microsporum canis DSM10708,  Microsporum 
gypseum DSM 3824. The strains obtained from PMC were: C. albicans 
(PMC 1011, PMC 1015, PMC 1023, PMC 1071, PMC 1075, PMC 1083, 
PMC 1088, PMC  1097), C. parapsilosis (PMC 0703, PMC 0711), C. 
tropicalis PMC 0908, C. krusei (PMC 0613, PMC 0625, PMC 0639),  C. 
glabrata (PMC 0805, PMC 0821, PMC 0843), C. neoformans (PMC 2103,  
PMC 2107, PMC 2111, PMC 2123, PMC 2136, PMC 2138, PMC 2142, 
PMC 2157, PMC 2169, PMC 2185),  T. mentagrophytes ( PMC 6503, PMC 
6509, PMC 6515, PMC 6527, PMC 6531, PMC 6552), T. rubrum PMC 
6612, M. gypseum (PMC 7303, PMC 7331, PMC 7342), M. canis PMC 
7426. All the strains were stored at -70°C in 10-15% glycerol solution 
(CLSI 2008a; CLSI 2008b). Yeasts were grown on sabouraud dextrose 
agar (Sigma-Aldrich, St. Louis, Missouri, U.S.A) plate for 24-48h at 35°C, 
in accordance with the procedures of the Clinical and Laboratory 
Standards Institute (CLSI) (CLSI 2008a). Dermatophytes were grown on 
potato dextrose agar (Sigma-Aldrich, St. Louis, Missouri, U.S.A) at 30°C 
for 4-5 days or until good conidial growth was obtained (CLSI 2008b).  
Antifungal susceptibility testing 
In vitro antifungal susceptibility was evaluated using the total extracts 
from untreated and treated roots obtained on the 15th day of culture, and 
from isolated and purified xanthones. The tests were conducted in 
accordance with the CLSI M27-A3 and CLSI M38-A2 broth 
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microdilution methods (CLSI 2008a; CLSI 2008b). Yeast and 
dermatophyte inocula were prepared as described in the CLSI protocols. 
The antifungal references amphotericin B  and fluconazole (Sigma-
Aldrich, St. Louis, Missouri, U.S.A.) were also tested (ranges: 0.031 to 16 
µg ml-1 for amphotericin B and 0.0078 to 250 µg ml-1 for fluconazole). 
The final concentrations ranged from 1000 to 1 µg ml-1 for total extracts 
and from 64 to 0.125 µg ml-1 for single xanthones. Microdilution trays 
containing 100 µl of serial two-fold dilutions of each substance in RPMI 
1640 medium (Sigma-Aldrich, St. Louis, Missouri, U.S.A) were 
inoculated with an organism suspension adjusted to attain a final 
inoculum concentration of 1.0 x 103 - 1.5 x103 cells ml-1 for yeasts and 
0.4x104 - 5x104 CFU ml-1 for dermatophytes. The panels were incubated 
at 35°C and observed for the presence of growth at 48 h (Candida spp.) 
and 72 h (C. neoformans and dermatophytes). Quality control was 
performed by testing the CLSI-recommended strain C. parapsilosis ATCC 
22019 (CLSI 2008c). The minimum inhibitory concentration (MIC) was 
defined as, for yeasts, the lowest concentration that showed ≥50% 
growth inhibition (MIC50) compared with the growth control and, for 
dermatophytes, the lowest concentration that showed ≥80% reduction 
in growth (MIC80) with respect to the growth control. However, when 
testing strains against amphotericin B, the MIC was defined as the lowest 
concentration that prevented any discernible growth (MIC100). The 
MIC100 was also evaluated for all of the substances. All of the 
experiments were performed in triplicate on three consecutive test days. 
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Cell viability assay 
Human leukemic monocyte lymphoma cells (U937) were obtained from 
the American Type Culture Collection (ATCC CRL1593.2,- Rockville, 
MD, U.S.A.). The cells (2x104 cells well-1) were seeded into 96-well plates 
containing 100 µl of supplemented RPMI1640 (Invitrogen, San Diego, 
CA, U.S.A.) without phenol red, supplemented with 10% fetal bovine 
serum (Invitrogen, San Diego, CA, U.S.A.), L-glutamine (0.3 mg ml-1), 
penicillin (100U ml-1) and streptomycin (100 µg ml-1) (EuroClone- 
Celbio, Milano, Italy), and they were cultured at 37°C in 5% CO2. Total 
extracts, dissolved in dimethyl sufoxide (DMSO), from untreated and 
treated roots obtained on the 15th day of culture (with concentrations 
ranging from 64 to 1000µg ml-1) were added to the wells. Each 
concentration and control was assayed in four replicates with at least five 
concentrations. The cells were cultured at 37° C and 5% CO2 for 24 h, 
and cell viability was determined using an MTT-assay (Sigma-Aldrich, St. 
Louis, Missouri, U.S.A.) (Mosmann 1983). MTT solution was added to 
each well in an amount equal to 10% of the culture volume, and the 
plates were incubated for 3-4 h at 37°C in 5% CO2. MTT solvent 
(Sigma-Aldrich, St. Louis, Missouri, U.S.A.) was successively added to 
dissolve the intracellular crystal. The plates were then incubated at 37° C 
in 5% CO2 for 1 h, and the optical density of each well was measured 
spectrophotometrically at 570 nm. The cytotoxicity of the root extracts 
was calculated as the percentage reduction in viable cells with respect to 
the control culture (cells treated with DMSO only). The 50% cytotoxic 
concentration (CC50) was evaluated as the drug concentration required to 
reduce human cell viability by 50% compared to the drug-free control.  
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Statistical analysis 
The arithmetic mean and Standard Deviation (SD) were calculated. The 
significance of the differences between the means was tested by a two-
tailed Student‟s t-test. P<0.05 was considered to be significant; P<0.001 
was considered to be highly significant.  
 
Results 
Induction and development of adventitious roots  
The seeds of HPA germinated within 2 days. On the 8th day of culture, 
cotyledons were evident. Leaf and stem explants from 2-month-old 
seedlings were inoculated in a callogenic medium. After 28 days of 
culture, the callus, which was cream colored and friable, was transferred 
to HF medium, to induce root regeneration. Twenty days later, 
regenerated roots were visible. When roots reached a length of 2-3 cm, 
they were separated from the callus and subcultured in the same 
medium. Their growth in length was initially very slow, but they grew 
rapidly after about 30 days of culture. The roots showed regular 
morphology and structure. 
 
The effect of IBA on biomass growth and xanthone production 
To achieve the most suitable culture conditions, the roots were 
cultivated in MS liquid medium supplemented with different 
concentrations of IBA (0, 0.5, 1, 1.5 and 2 mg l-1). Root biomass increase 
was monitored for 23 days based on the growth curve (Fig. 3a). In this 
system the log phase ended on the 18th day of culture and no additional 
increase in biomass was observed until the 23rd day. Concerning biomass 
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increase, the highest growth indexes (8.5 and 9.5) were registered for 
roots cultivated in the presence of the highest IBA concentrations (Fig.1) 
(1.5 and 2 mg l-1), yet in these conditions the roots showed callus 
formation. In the medium supplemented with 1 mg l-1 IBA, the roots 
showed a growth index of 6.5, which corresponded to a 7.5 increase in 
biomass with respect to the initial inoculum. Even if the biomass 
increase with IBA 1.5 and 2 mg l-1 was significantly higher (P<0.05) than 
with IBA 1 mg l-1, this last medium has been chosen because it allowed 
the formation of morphologically unaltered roots. This medium was also 
found to have been the most suitable to induce a significant higher 
(P<0.05) xanthone accumulation (Fig. 2) (3.26 ± 0.09 mg g-1 DW).  
 
 
Figure 1 Biomass increase (g DW) for roots cultivated in MS medium supplemented 
with different concentrations of IBA (0; 0.5; 1; 1.5; 2 mg l-1). Results are means (±SD) of 
three independent replicates. Different letters refer to significant differences (P<0.05). 
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Effect of chitosan treatment on root biomass growth 
The growth curve of root biomass was recorded during a culture cycle of 
23 days (Fig. 3a). Chitosan, which was added during the exponential 
phase (8th day of culture), resulted in a cessation in growth and a 
decrease in biomass. 
 
Figure 2 Total xanthone accumulation (mg gDW-1) in roots cultivated in MS medium 
supplemented with different concentrations of IBA (0; 0.5; 1; 1.5; 2 mg l-1). Results are 
means (±SD) of three independent replicates. Different letters refer to significant 
differences (P<0.05). 
 
 
Xanthone production in untreated and chitosan-treated roots 
The HPLC analysis showed that chitosan treatment greatly, though only 
transiently, enhanced xanthone production. Xanthone accumulation in 
untreated roots did not vary dramatically during the culture period (Fig. 
3b), with a mean of 4.5± 1.5 mg g-1 DW.  
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The major xanthones accumulated in the untreated roots were 1,7-
dihydroxyxanthone, 5-methoxy-2-deprenylrheediaxanthone B, and 
paxanthone. 1,7-dihydroxyxanthone was detected from the beginning of 
the culture period until the 15th day, whereas afterwards it was not 
detected (Table 1). The xanthone profile in treated root extracts was 
qualitatively similar to the one in untreated root extracts. In treated 
roots, total xanthone accumulation peaked 7 days after treatment (which 
corresponded to the 15th day of culture) at 14.26±0.62 mg g-1 DW, 
which is significantly higher (P<0.05) than the accumulation in the 
control on the same day of culture. 
Afterwards, total xanthone accumulation rapidly decreased, until 
reaching 3.01±0.09 mg g-1 DW on the 23rd day of culture, which is 
similar to that for untreated roots (3.26±0.09 mg g-1 DW) (Fig. 3b). 
Moreover, the peak accumulation of 1,7-dihydroxyxanthone in treated 
roots (7 days after treatment) was 10-times higher than the accumulation 
in untreated roots. 
Xanthone release in the culture medium 
The HPLC analysis of the culture media of treated and untreated roots 
showed qualitatively similar chemical profiles for xanthones, with 1,7-
dihydroxyxanthone being the main compound in all of the extracts 
(Table 2). Total xanthone release was significantly enhanced by chitosan 
(P<0.05), peaking on the 15th day of culture (7 days after treatment) at 
2.64±0.13 mg g-1 DW (21.12 mg l-1 medium); 1.7±0.1 mg g-1 DW (13.6 
mg l-1 medium) of the total xanthone release was represented by 1,7-
dihydroxyxanthone. 
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Figure 3 (a) Growth curves of untreated and chitosan-treated root cultures; (b) 
accumulation and (c) release of detected xanthones by root cultures of HPA, throughout 
the growth period. Results are means (±SD) of three independent replicates. The straight 
arrow in (a) indicates the day of chitosan treatment. 
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Antifungal activity 
The antifungal activity of the extracts obtained from untreated and 
treated roots at the 15th day of culture was evaluated against strains of 
Candida spp., C. neoformans and dermatophytes. Chitosan increased the 
antifungal activity against all of the strains tested. In particular, for the 
treated roots, the MIC range against Candida spp. strains was 16-250 µg 
ml-1, compared to 64-1000 µg ml-1 for untreated roots (Table 3). 
Regarding the extracts from treated roots, when comparing strains of 
Candida non-albicans species with C. albicans, the MIC range was, 
respectively, 16-250 µg ml-1 and  64-250 µg ml-1 (Table S1 in the 
electronic supplementary material). For strains of C. neoformans, the MIC 
range was 16-125 µg ml-1 for treated-root extracts and 64-250 µg ml-1  
for untreated-root extracts. For dermatophyte strains, the MIC range was 
64-125 µg ml-1 and 125-500 µg ml-1 for treated-root and untreated-root 
extracts, respectively (Tables 4 and 5) (additional data are given in on line 
resource Tables S2 and S3). 
The difference in MIC between treated and untreated roots was highly 
significant (two-tailed Student‟s t-test: P<0.001) for Candida and 
Cryptococcus strains (Tables 3 and 4) and significant (P<0.05) for 
dermatophytes (Table 5). Total growth inhibition (MIC100) for all tested 
strains was obtained with concentrations ranging from about 125 to 
1000 µg ml-1. The main xanthones isolated and purified from treated-
root extracts (1,7-dihydroxyxanthone, cadensin G, paxanthone, and 5-
methoxy-2-deprenylrheediaxanthone B) were also investigated for their 
antifungal activity; the MIC ranged from 4 to > 64 µg ml-1 (Tables 3, 4, 
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and 5) (additional data are given in on line resource Tables S1, S2 and 
S3). 1,3,5,6-tetrahydroxyxanthone and 1,3,6,7-tetrahydroxyxanthone 
have not been tested because, no one of the solvents used allowed their 
separation due to their structural similarity. 
 
Table 1 Xanthones detected in extracts of untreated (-) and chitosan-
treated (+) roots. 
 Day 8 Day 11 Day 15 Day 18 Day 23 
Xanthones - 
mg g-1 
DW 
+ 
 mg g-1 
DW 
- 
mg g-1 
DW 
+ 
mg g-1 
DW 
- 
mg g-1 
DW 
+ 
 mg g-1 
DW 
- 
mg g-1 
DW 
+ 
 mg g-1 
DW 
- 
mg g-1 
DW 
+ 
mg g-1 
DW 
1, 2 nd nd nd 0.75 
±0.02 
0.37 
±0.01 
1.2 
±0.04 
0.35 
±0.01 
0.88 
±0.03 
0.32 
±0.01 
nd 
3 1.93 
±0.09 
1.93 
±0.09 
1.5 
±0.04 
1.18 
±0.03 
0.83 
±0.02 
8.36 
±0.39 
nd 5.04 
±0.23 
nd 0.69 
±0.02 
4 2.04 
±0.1 
2.04 
±0.01 
1.5 
±0.05 
1.18 
±0.04 
0.83 
±0.02 
nd 0.66 
±0.02 
Nd 0.52 
±0.01 
0.56 
±0.02 
5 0.74 
±0.02 
0.74 
±0.02 
0.44 
±0.01 
1.16 
±0.02 
0.35 
±0.01 
2.48 
±0.12 
0.83 
±0.03 
1.12 
±0.01 
0.75 
±0.02 
0.54 
±0.02 
6 0.85 
±0.03 
0.85 
±0.03 
0.66 
±0.01 
0.78 
±0.01 
0.53 
±0.02 
1.44 
±0.05 
0.62 
±0.01 
1.57 
±0.02 
0.83 
±0.03 
0.64 
±0.02 
7 0.71 
±0.01 
0.71 
±0.01 
0.39 
±0.01 
1.2 
±0.02 
0.73 
±0.03 
0.78 
±0.02 
0.96 
±0.03 
0.46 
±0.01 
0.84 
±0.02 
0.58 
±0.01 
Total 6.21 
±0.21 
6.28 
±0.21 
4.49 
±0.12 
6.25 
±0.14* 
3.64 
±0.11 
14.26 
±0.62* 
3.42 
±0.10 
9.07 
±0.30* 
3.26 
±0.09 
3.01 
±0.09 
The data are the means ± standard error of three replicates. (1,2) 1,3,5,6-
tetrahydroxyxanthone and 1,3,6,7-tetrahydroxyxanthone (it is a mixture of both); (3) 1,7-
dihydroxyxanthone; (4) cadensin G; (5) toxyloxanthone B; (6) paxanthone; (7) 5-O-
methyl-2-deprenylrheediaxanthone B. DW=dry weight; nd= not detected. *, P<0.05 
(versus control roots, by Student's t-test).  
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Table 2 Xanthones detected in culture media of untreated (-) and 
chitosan-treated (+) roots.  
 Day 8 Day 11 Day 15 Day 18 Day 23 
Xanthones - 
mg g-1 
DW 
+ 
mg g-1 
DW 
- 
mg g-1 
DW 
+ 
 mg g-1 
DW 
- 
mg g-1 
DW 
+ 
mg g-1 
DW 
- 
mg g-1 
DW 
+ 
mg g-1 
DW 
- 
 mg g-
1 DW 
+ 
mg g-1 
DW 
1, 2 nd nd nd 0.4 
±0.01 
nd 0.37 
±0.01 
nd nd nd nd 
3 1.06 
±0.08 
1.06 
±0.08 
0.44 
±0.01 
0.42 
±0.01 
0.33 
±0.01 
1.7 
±0.1 
nd 1.35 
±0.15 
nd 0.54 
±0.02 
4 nd nd nd 0.37 
±0.01 
nd nd 0.21 
±0.01 
0.42 
±0.02 
0.12 
±0.01 
0.72 
±0.02 
5 nd nd nd 0.34 
±0.01 
0.32 
±0.01 
nd 0.20 
±0.01 
0.42 
±0.02 
0.18 
±0.01 
Traces 
6 nd nd nd nd nd 0.31 
±0.01 
0.21 
±0.01 
nd 0.23 
±0.01 
Traces 
7 0.66 
±0.01 
0.66 
±0.01 
0.34 
±0.01 
nd 032 
±0.01 
0.26 
±0.01 
0.22 
±0.01 
nd 0.14 
±0.01 
nd 
Total 1.72 
±0.09 
1.72 
±0.09 
0.78 
±0.02 
1.53 
±0.04* 
0.97 
±0.03 
2.64 
±0.13* 
0.84 
±0.04 
2.19 
±0.19* 
0.67 
±0.04 
1.26 
±0.04* 
The data are the means ± standard error of three replicates. (1,2) 1,3,5,6-
tetrahydroxyxanthone and 1,3,6,7-tetrahydroxyxanthone (it is a mixture of both); (3) 1,7-
dihydroxyxanthone; (4) cadensin G; (5) toxyloxanthone B; (6) paxanthone; (7) 5-O-
methyl-2-deprenylrheediaxanthone B. DW=dry weight; nd= not detected. *, P<0.05 
(versus control roots, by Student's t-test) 
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Table 3 Antifungal activity of total extracts from untreated and 
chitosan-treated roots of HPA obtained on the 15th day of culture and 
isolated and of purified xanthones against 30 Candida strains (16 C. 
albicans, 4 C. parapsilosis, 2 C. tropicalis, 4 C. krusei, 4 C. glabrata) 
 
 
MIC±SD 
(µg ml-1) 
MIC range 
(µg ml-1) 
MIC100 
(µg ml-1) 
QC strain MIC 
(µg ml-1) 
Control roots 281.2±198  64-1000 838.5±267  125 
Treated roots 83.4±52.4* 16-250 489.6±260 32  
3 >64 >64 >64 16 
4 >64 >64 >64 32 
6 >64 >64 >64 64 
7 >64 >64 >64 8 
Amphotericin  B n.d. 0.125-16 2.68±3.8 0.5  
Fluconazole 2.57±4.06 0.125-16 95.5±122   2 
*(3) 1,7-dihydroxyxanthone; (4) cadensin G; (6) paxanthone; (7) 5-O-methyl-2-
deprenylrheediaxanthone B. MIC=arithmetic mean of minimum inhibitory 
concentration; SD= standard deviation; MIC100=lowest drug concentration that 
prevented any discernible growth with respect to the untreated control; QC=quality 
control strain; data represent mean of three separate experiments in triplicate. n.d.=not 
determined. *, P<0.001 (versus control roots, by Student's t-test) 
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Table 4 Antifungal activity of total extracts from untreated and 
chitosan-treated roots of HPA obtained on the 15th day of culture and 
isolated and of purified xanthones against 12 strains of C. neoformans. 
 
 
MIC±SD 
(µg ml-1) 
MIC range 
(µg ml-1) 
MIC100 
(µg ml-1) 
Control roots 99±55.5  64-250 333±119  
Treated roots 39.1±19* 16-125 146±46  
3 >64 >64 >64 
4 44± 15.6  32-64 >64 
6 >64 >64 >64 
7 42±15  32-64 >64 
Amphotericin B n.d. 0.016-4 1.63±1.55 
Fluconazole 2.23± 1.57  0.5-8 15.1±17.7 
*(3) 1,7-dihydroxyxanthone; (4) cadensin G; (6) paxanthone; (7) 5-O-methyl-2-
deprenylrheediaxanthone B. MIC=arithmetic mean of minimum inhibitory 
concentration; SD= standard deviation; MIC100=lowest drug concentration that 
prevented any discernible growth with respect to the untreated control; QC=quality 
control strain; data represent mean of three separate experiments in triplicate. n.d.=not 
determined. *, P<0.001 (versus control roots, by Student's t-test) 
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Table 5 Antifungal activity of total extracts from untreated and 
chitosan-treated roots of HPA obtained on the 15th day of culture and 
isolated and of purified xanthones against 16 dermatophytes (8 T. 
mentagrophytes, 2 T. rubrum, 4 M. gypseum, 2 M. canis). 
 MIC±SD 
(µg ml-1) 
MIC range 
(µg ml-1) 
MIC100 
(µg ml-1) 
Control roots  321±164 125-500 642±305 
Treated roots 114±235* 64-125 229±47 
3 34±20 4-64 >64 
4 >64 >64 >64 
6 >64 >64 >64 
7 46±17  16-64 >64 
Amphotericin B n.d. 0.125-8 4.8±3.1  
Fluconazole 11.6±10.4 1-32 39±37.5 
(3)1,7-dihydroxyxanthone; (4)cadensin G; (6)paxanthone; (7)5-O-methyl-
deprenylrheediaxanthone B. MIC=arithmetic mean of minimum inhibitory 
concentration, SD=standard deviation; MIC100=lowest drug concentration that prevents 
any discernible growth with respect to the untreated control; data represent mean of 
three separate experiments in triplicate. n.d.=not determined. *, P<0.05 (versus control 
roots, by Student's t-test) 
 
Cytotoxic activity 
The cytotoxicity of extracts obtained from untreated and treated roots at 
the 15th day of culture was evaluated against mammalian cells (U937). 
The CC50 was calculated. For both untreated and treated root extracts, 
the CC50 was >1000 µg ml-1 . 
 
Discussion  
In a comparative study of H. perforatum subspecies, using in-field grown 
plants, the accumulation of secondary metabolites was greater for HPA, 
compared to the other subspecies (Males et al. 2006). Xanthones with 
interesting biological activities have been found in H. perforatum total 
plant extracts (Kitanov and Blinova 1987; Holzl et al. 1989; Nahrstedt 
and Butterweck 1997). In an in vitro study of H. perforatum, Pasqua et al. 
 86 
 
(2003) demonstrated that xanthones were accumulated in the roots 
regenerated from plantlets or formed by callus. These results were 
confirmed in an unpublished study on HPA, in which we found that in 
naturally grown plants xanthones were mainly accumulated in the roots, 
yet in very low quantities, ranging from 200 to 500 µg g-1 DW 
(unpublished). We also observed that xanthone accumulation greatly 
depended on the season, the soil composition, and the developmental 
stage of the plant. For these reasons, it is very difficult to recover an 
exploitable and standardized extract containing xanthones from natural 
sources.  
To overcome these problems, we focused on in vitro regenerated root 
cultures as a biotechnological system for obtaining standardized extracts 
containing xanthones. The large-scale cultivation of untransformed roots 
for producing important phytochemicals has been achieved for 
medicinal plants such as Nothapodytes foetida (Fulzele et al. 2002), Panax 
notoginseng (Gao et al. 2005), and Echinacea purpurea (Wu et al. 2007). 
Although root cultures of H. perforatum have also been established by 
other authors (Cui et al. 2010; Goel et al. 2009), the capacity of these 
cultures to produce xanthones has never been explored.  
As reported by many authors (Pasqua et al. 2003; Zobayed et al. 2004; 
Franklin and Dias 2006) H. perforatum has a high capacity for 
regeneration, and in our study root regeneration from calli was very 
easily achieved. The  roots were cultivated with IBA, based on our 
preliminary results and on the results of studies on H. perforatum root 
cultures conducted by Cui et al. (2010) and Goel et al. (2009). According 
to these studies, IBA and IAA were more effective for lateral root 
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induction and root growth, whereas NAA was not effective and induced 
callused roots.  Moreover, we chose to use IBA because it is more stable 
than IAA; in fact, many reports stress that IAA is unstable in culture 
media at room temperature. Root biomass was positively correlated with 
the IBA concentration (Fig. 1), though a concentration of 1 mg l-1 was 
the most suitable to obtain morphologically unaltered roots. 
The highest concentrations of IBA inhibited xanthone accumulation 
(Fig. 2), confirming reports that high auxin levels are often deleterious to 
secondary metabolite accumulation in other species (Dornenburg and 
Knorr 1995; Chan et al. 2005).  
In our study, xanthones were produced in large amounts, with a very 
stable trend throughout the culture period. To stimulate xanthone 
accumulation chitosan, a polymer that is able to stimulate the 
biosynthesis of xanthones in cell cultures of HPA (Tocci et al. 2010) was 
used. Chitosan acts as an external stimulus on plant cells, which is 
recognized by receptors localized on the plasma membrane, leading to 
the induction of a defense response (oxidative burst and phytoalexin 
production) without penetrating the cell (Kaku et al. 2006). Chitosan 
treatment resulted in a cessation in growth and a decrease in biomass. 
Moreover, after elicitation, the xanthone content in roots dramatically 
increased, peaking after 7 days. This increase supports the hypothesis 
that xanthones act as a phytoalexin, playing a role in the chemical 
defense of the plant against fungal pathogens (Franklin et al. 2009). 
Fifteen days after treatment with chitosan, the xanthone content 
decreased, and the level at the end of the culture period, day 23, was 
similar to that of the untreated control. Moreover, after chitosan 
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treatment, we observed an increased accumulation of these metabolites 
in the culture medium (Fig. 3c), which constitutes an important 
advantage for a future scale-up of the production process for the easy 
recovery of bioactive substances, without destroying plant material.  
Our results suggest that root cultures can be considered as a potential 
tool for large-scale xanthone production, in that accumulation is much 
higher than that found in the roots of naturally grown plants, and root 
cultures possess suitable characteristics for a successful scale-up: high 
biomass growth, stable production of secondary metabolites, sensitivity 
to external stimuli, and metabolite release in the culture medium.  
Regarding the antifungal activity of the extracts, an encouraging level was 
observed for all of the fungal strains tested: Candida spp., the main agent 
responsible for nosocomial fungal infections (Pfaller and Diekema 2010); 
C. neoformans, a common life-threatening human fungal pathogen 
(Mitchell and Perfect 1995); and dermatophytes, which are responsible 
for fungal skin infections (Seebacher et al. 2008). This activity 
significantly increased when using chitosan, and high activity was found 
for extracts obtained after 7 days of treatment (mean MIC of 83.4 µg ml-
1, 39.1 µg ml-1 and 114 µg ml-1 against, respectively, Candida spp, C. 
neoformans, and dermatophytes). The higher antifungal activity found for 
extracts from treated roots might be explained by the greater 
accumulation of xanthones in these roots. Further studies are needed to 
determine whether the observed activity is the consequence of an 
increase in xanthones or other unidentified compounds produced in 
response to elicitation. The increased amount of xanthones and the 
corresponding improved antifungal activity of the extracts suggest that 
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xanthones could be the principal constituents responsible for the 
antifungal activity. Metabolomic analyses are currently being performed 
to better clarify the extract composition and to perform purification of 
xanthone-rich fractions to be tested for antifungal activity. 
In conclusion, the system described herein is an efficient means of 
obtaining root biomass which is not subject to pedoclimatic variations or 
antropic contaminants and which allows extracts with stable quantities of 
xanthones and good antifungal activity to be obtained. The cytoxicity 
tests were performed to demonstrate that the root extracts are not toxic 
for animal cells and to continue studies for an eventual applicative use in 
human disease. Our preliminary cytotoxicity analyses show a low 
cytotoxicity of extracts on mammalian cells, though further studies need 
to be performed.  
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Annex 1 
Isolation and chemical characterization of xantones 
 
Materials and methods 
Xanthones from roots were isolated applying different methodologies: 
 Exclusion size chromatrography on LH-20 resin (Sigma, ),using 
methanol as eluent 
 Column chromatography with Silicagel 60 (0.063-0.200 mm) 
(Merk, ), using ethyl acetate/ hexan 1:1 or 1:2 according to the 
sample characteristics.  
 Reverse phase chromatography performed on a LiChroprep RP-
18 (40-63 µm) column (Merck chemicals) connected to a 
Duramat pump working at 70 bar, and a gradient of methanol 
10-50 % as eluent. 
 Thin Layer Chromatography (TLC) on alumina plates covered 
with silica gel 60 fluorescent at 254 nm or RP8  (Merck) with 
various elution systems. 
 Preparative TLC on glass plates (20x20 cm) coated with silica 
gel 60 (250 µm) and fluorescent at 254 nm, using as mobile 
phase hexan/ ethyl acetate 1:1 or 1:2 according to the 
characteristics of the sample. 
The spots on TLC were visualized by spraying a solution of solphoric 
acid, phormaldeyde and water on the plates and exposing the plates at 
high temperatures. The H-NMR spectra were performed in deuterate 
acetone in a Varian Gemini 200 Spectrometer. 
 101 
 
Results 
Isolation of 1,7-dihydroxyxanthone 
 
Figure 1 Schematic representation of isolation procedure for 1,7-dihydroxayxanthone. 
LH20, size exclusion chromatography; CC RP8, reverse phase column chromatography. 
 
 
 
 102 
 
Figure 2 HPLC chromatogram of the isolated 1,7-dihydroxyxanthone. 
 
1H NMR data for 1,7-dihydroxyxanthone in acetone-d6: 
δ: 7.71 (H-3, t, J = 8.0 Hz), 7.62 (H-5, d, J = 3.2 Hz), 7.54 (H-8, d, J= 9.2 
Hz), 7.45 (H-7, dd, J= 9.2 e 3.2 Hz), 7.02 (H-4, bd), 6.78 ( H-2, bd).  
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Isolation of 5-O-methyl-2-deprenylrheediaxanthone B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Schematic representation of isolation procedure for 5-O-methyl-2-
deprenylrheediaxanthone B. LH20, size exclusion chromatography; SiO2, column 
chromatography on silica gel; TLC prep., preparative TLC. 
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Figure 4 HPLC chromatogram of the isolated 5-O-methyl-2-deprenylrheediaxanthone 
B. 
 
 
1H NMR data for 5-O-metil-2-deprenilrheediaxantone B in 
acetone-d6 
δ: 13.40 (OH-1, s ), 7.85 (H-8, d, J = 8.7 Hz ),  7.03 (H-7, d, J = 8.7 Hz), 
6.18 (H-2, s), 4.60 (H-2‟, q, J = 6.6 Hz), 4.02 (OMe, s), 1.65 (4‟-CH3 , s), 
1.43 (3‟-CH3, d, J= 6.6 Hz), 1.35 (5‟- CH3, s) 
 
  
A
U
0,00
0,10
0,20
0,30
Minutes
0,00 5,00 10,00 15,00 20,00 25,00 30,00 35,00 40,00 45,00 50,00 55,00 60,00 65,00 70,00
 105 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter  6: 
Establishment of a three-step-culture system and 
optimization of xanthone production   
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Root cultures of Hypericum perforatum subsp. angustifolium revealed to be a 
potential tool for the production of xanthone-rich extracts.  It is known 
that in vitro organ growth and secondary metabolite production are often 
governed by different combinations of growth regulators and that plant 
secondary metabolism is generally stimulated when cell growth is slowed. 
In the light of these assumptions, experiments to test the effect of 
growth regulators on xanthone production and root growth were 
performed and a three-step culture system was established. The first step 
consisted of culturing roots in a medium stimulating organ biomass 
increase; the second step consisted of subculturing roots in a medium 
enhancing secondary metabolite production and the third step  in the 
addition of chitosan to  further increase total xanthones. The resulting  
xanthone-rich extract has been tested for  antifungal activity to confirm a 
positive linear correlation between xanthones and antifungal activity.  
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Chapter 7: 
A three-step culture system to increase the xanthone 
production and antifungal activity of Hypericum 
perforatum subsp. angustifolium in vitro roots 
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ABSTRACT 
Hypericum perforatum is a well-known medicinal plant. Among all 
secondary metabolites produced by this species, xanthones are very 
interesting for their antifungal activity. In the present study, with the aim 
to improve xanthone production and antifungal activity of Hypericum 
perforatum subsp. angustifolium (sin. Fröhlich) Borkh in vitro roots, a new 
methodology consisting of a three-step culture system, has been 
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developed. Regenerated roots of Hypericum perforatum were cultured in a 
three-step culture system: in the first step, to increase biomass, the roots 
were cultured in half-strength liquid Murashige and Skoog (MS) medium 
supplemented with 1 mg L-1 indole butyric acid (IBA) and 1.5% sucrose. 
In the second and third steps, to stimulate secondary metabolism, the 
roots were cultured with 1.1 mg L-1 2,4-dichlorophenoxyacetic acid (2,4-
D), 0.215 mg L-1 kinetin (KIN), and 0.186 mg L-1 1-naphthalenacetic acid 
(NAA). In the third step, some of the roots were treated with chitosan. 
Xanthone production increased 2.7 times following the three-step 
method. The highest minimal inhibitory concentration (MIC) values 
were of 36.9, 26.7, and 65 µg mL-1, against Candida species, Cryptococcus 
neoformans and dermatophytes, respectively.  
A positive correlation between xanthone accumulation and antifungal 
activity has been shown.  
 
Key words: Hypericum perforatum, xanthones, three-step root culture 
system, Candida species, Cryptococcus neoformans, dermatophytes 
 
Abbreviations: MS, Murashige and Skoog; IBA, indole butyric acid; 2,4-D, 
2,4-dichlorophenoxyacetic acid; KIN, kinetin; NAA, 1-naphthalenacetic 
acid; MIC, minimal inhibitory concentration  
 
1. Introduction 
In the past 30 years there has been a dramatic increase in the incidence 
of fungal infections [1] and a consequent greater need for effective 
therapy. However, only a limited range of antifungal agents are available, 
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and some of the most effective agents are toxic. Furthermore, clinical 
efficacy may be compromised by intrinsic or acquired drug resistance [2]. 
The increasing resistance of pathogenic fungi to antifungal compounds 
and the reduced number of available drugs has led to the search for 
therapeutic alternatives among natural products. In recent years, many 
studies have been published on the antifungal activity of plant-derived 
phenolic compounds, including xanthones [3,4]. Several authors have 
reported the antifungal activity of a broad range of both synthetic and 
naturally occurring xanthones with respect to Candida, Cryptococcus, and 
dermatophytes. In particular, natural and synthetic oxygenated xanthones 
have been found to be active mainly on dermatophytes [5]. The 
xanthone α-mangostin, extracted from the fruit of Garcinia mangostana, 
has been shown to inhibit the growth of Candida albicans at 1000 µg mL-
1[6]. Toxyloxanthone C, isolated from the roots of Cudrania fruticosa, has 
shown antifungal activity against Candida albicans, with minimal inhibitory 
concentrations of 25 µg mL-1 [7]. Xanthones isolated from the roots of 
Hypericum roeperanum have exhibited antifungal activity against Candida 
albicans [8], whereas nothing is known about the activity of extracts from 
H. perforatum roots. However, the content of bioactive compounds 
extracted from wild plants is not constant and may change according to 
the developmental stage of the plant, the season, and environmental 
factors. In vitro cultures are an attractive tool for obtaining extracts rich 
in bioactive metabolites which are not subject to fluctuation. The 
potentiality of Hypericum perforatum cell cultures to produce xanthones has 
been already demonstrated by the authors [9]. 
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Moreover, we recently established root cultures of H. perforatum subsp. 
angustifolium to obtain extracts with a stable chemical composition [10]. 
The extracts showed antifungal activity against human pathogenic fungi, 
and there was a positive linear relationship between antifungal activity 
and xanthone content in the root extracts. In vitro organ growth and 
secondary-metabolite production are often governed by different 
combinations of growth regulators. In light of our previous results, in 
this study we developed a method to increase the content of bioactive 
metabolites in the extracts; in particular, we applied a new culture system 
consisting of three steps which differ in the type and concentration of 
the growth regulators and by the addition of an elicitor. Herein we report 
the results of the application of this system in terms of the production of 
bioactive metabolites and antifungal activity against Candida species, 
Cryptococcus neoformans and dermatophytes of H. perforatum in vitro roots. 
 
2. Results 
To achieve the most suitable culture conditions in terms of biomass and 
secondary metabolite production, the roots were cultured in a newly 
developed three-step system. In the first step, the roots, which were 
cultured in Medium 1, showed a growth index (GI) of 5.4, which 
corresponded to a 6.4-fold increase in biomass with the respect to the 
initial inoculum (Fig. 1A). In the second step, although the GI of the 
roots cultured in Medium 2 (Fig 1A) was significantly lower (P<0.05) 
than the GI of the roots cultured in Medium 1, xanthone production was 
3.53 times higher (i.e., 12.84 mg g-1 DW vs. 3.64 mg g-1 DW) (Fig. 1B). 
The third step, which included the addition of chitosan as an elicitor, led 
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to a further increase in total xanthone content (1.4 times higher than that 
in the untreated roots) (P< 0.05) (Fig. 1B). Xanthone production in both 
chitosan-treated and untreated roots peaked at day 15 of culture and 
then gradually decreased (Fig. 1B). Chitosan induced an increase for all 
of the xanthones (Table 1).  
The main xanthones accumulated were: 5-methoxy-2-
deprenylrheediaxanthone B and paxanthone Table 1 and Fig. 2). 
Moreover, the chitosan-treated roots produced 1,7-dihydroxyxanthone, 
which was not detected in the untreated roots (Table 1). After the 
addition of chitosan, no negative effects were observed on root vitality, 
although it led to a lower growth of biomass (Fig. 1A). In Table 2, the 
antifungal activity of roots transferred to Medium 2 and those 
maintained in Medium 1 is shown. The mean MIC value for roots 
cultured in Medium 2, compared to the mean MIC value for roots 
maintained in Medium, was 10 times lower for C. albicans, 5.4 times 
lower for the non-albicans Candida species, 5.9 times lower for C. 
neoformans and 5.2 times lower for dermathopytes. In the third step, the 
addition of chitosan led to an increase of antifungal activity with the 
mean MIC values of 36.9 µg mL-1 for Candida spp., 26.7 µg mL-1 for C. 
neoformans, and 65 µg mL-1 for dermatophytes (Table 3). Moreover, the 
root extracts showed a low cytotoxicity for both MDCK and HeLa cells 
(i.e., CC50 >500 µg mL-1). 
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Fig. 1. (A) Growth curves of roots cultured in the Media 1, Medium 2 and Medium 2 
supplemented with chitosan. (B) Accumulation of xanthones in roots cultured in the 
Media 1, Medium 2  and Medium 2 supplemented with chitosan  during the entire 
growth period. Results are expressed as means (±SD) of three independent replicates. (◊) 
Medium 1, (□)  Medium 2, ▲ Medium 2 supplemented with chitosan.  
 
 
 
 
 
 
Fig. 2. Chromatographic profile at 260 nm of the extract from roots cultured in Medium 
2 supplemented with chitosan, at day 15 of culture. Xanthones: (1, 2) 1,3,5,6-
tetrahydroxyxanthone and 1,3,6,7-tetrahydroxyxanthone, (3) 1,7-dihydroxyxanthone, (4) 
cadensin G, (5) toxyloxanthone B, (6) paxanthone, (7) 5-O-methyl-2-
deprenylrheediaxanthone B. 
 
 
 
 
 
A B 
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Table 1 Xanthones detected in the extracts of Hypericum perforatum subsp. angustifolium 
roots cultured in Medium 2 untreated (-) and treated with chitosan (+) (third step). 
 
a(1,2) mixture of 1,3,5,6-tetrahydroxyxanthone and 1,3,6,7-tetrahydroxyxanthone, (3) 1,7-
dihydroxyxanthone, (4) cadensin G, (5) toxyloxanthone B, (6) paxanthone, (7) 5-O-
methyl-2-deprenylrheediaxanthone B;  bDW=dry weight; nd= not detected;  cDifferent 
letters refer to significant differences (P<0.05).; The data are the means ± standard 
deviation of three replicates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Xanthonea Day 0 Day 8 Day 11 Day 15 Day18 Day 23 
- 
mg g-
1 
DWb 
- 
mg g-
1 DW 
- 
mg g-
1 DW 
+ 
mg g-
1 DW 
- 
mg g-
1 DW 
+ 
mg g-1 
DW 
- 
mg g-
1 DW 
+ 
mg g-1 
DW 
- 
mg g-
1 DW 
+ 
mg g-1 
DW 
1, 2 
0.3 
±0.01 
0.52 
±0.02 
0.47 
±0.02 
0.59 
±0.02 
nd 
1.01 
±0.08 
0.45 
±0.02 
0.6 
±0.03 
0.3 
±0.05 
0.67 
±0.02 
3 nd nd nd nd nd 0.99±0.06 nd 1.22±0.06 nd 0.45±0.01 
4 
0.53 
±0.02 
0.62 
±0.02 
0.66 
±0.03 
0.74 
±0.02 
1.38 
±0.07 
1.22 
±0.07 
0.58 
±0.03 
0.98 
±0.09 
0.53 
±0.03 
0.49 
±0.02 
5 
0.29 
±0.03 
0.43 
±0.01 
0.55 
±0.02 
0.92 
±0.03 
0.66 
±0.03 
1.06 
±0.03 
0.36 
±0.01 
1.34 
±0.12 
0.29 
±0.01 
1.3 
±0.03 
6 
1.54 
±0.06 
1.51 
±0.08 
1.4 
±0.08 
1.63 
±0.12 
2.37 
±0.09 
3.45 
±0.19 
1.53 
±0.12 
2.87 
±0.15 
1.54 
±0.15 
2.4 
±0.12 
7 
3.82 
±0.12 
4.45 
±0.07 
6.04 
±0.11 
6.75 
±0.25 
8.43 
±0.23 
9.89 
±0.23 
3.96 
±0.25 
6.76 
±0.35 
3.82 
±0.32 
7.64 
±0.25 
Total 
6.48 
±0.24 
(a)c 
7.43 
±0.18 
(b)c 
9.12 
±0.26 
(c)c 
10.63 
±0.54 
(d)c 
12.84 
±0.42 
(e)c 
17.62 
±0.66 (f)c 
6.88 
±0.43 
(a)c 
13.77 
±0.80 (e)c 
6.48 
±0.56 
(a)c 
12.95 
±0.45 (e)c 
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Table 2 Comparison of the antifungal activity of extracts of the Hypericum perforatum 
subsp. angustifolium roots grown and maintained in Medium 1 and those transferred to 
Medium 2 . 
 
3. Discussion  
The increasing occurrence of fungal infections is a major public-health 
concern, and additional antifungal agents must be developed to 
successfully control the human fungal pathogens that are resistant to 
available antifungals. Phytomedicine, which has historically been an 
important aspect of traditional medicine in non-industrialized countries, 
is now becoming an integral part of healthcare in industrialized nations. 
Plants are the source of thousands of new phytochemicals, and different 
strategies can be applied to improve the yields of bioactive metabolites in 
the plant and to obtain standardized extracts. We recently evaluated a 
biotechnological system, in vitro root cultures of H. perforatum subsp. 
angustifolium [10], as an effective method for obtaining qualitatively and 
quantitatively standardized extracts. 
 Roots in Medium 1 Roots in Medium 2 P valued  
 MIC ( µg mL-1) 
 
Strainse  
(number) 
MICa SDb Range MIC100c MICa SDb  Range MIC100c  
Candida  
albicans 
 (3) 
192 70.1 128-256 916.7 204.1 18.7 6.5 16-32 74.7 43.7 p<0.001 
non-albicans 
 Candida species  
 (6) 
343 270.3 128-1000 805 252 64 39.2 16-128 166.41 44.5 p<0.05 
Crytpcoccus 
 neoformans 
 (2)   
282 252 64-512 256 0 48 18.5 32-64 128 0  
Dermatophytes 
 (3) 
333 172 128-512 656 331 64 0 64 115.2 28.6 p<0.05 
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Table 3 Antifungal activity, against human fungal pathogens, of total extracts of 
Hypericum perforatum subsp. angustifolium roots collected at day 15 of the third step of 
culture.  
aMIC: arithmetic mean of minimal inhibitory concentration; bSD: standard deviation; 
cMIC100: lowest drug concentration that prevented any discernible growth with respect to 
the control; dT test statistical analysis for the evaluation of significance between the two 
media; a P value of <0.05 was considered significant and a P value of <0.001 was 
considered highly significant; eStrains tested: Candida albicans ATCC90028, ATCC90029, 
ATCC24433. Candida parapsilosis ATCC22019, Candida parapsilosis DSM11224, Candida 
parapsilosis DSM5784, Candida krusei DSM, Candida tropicalis DSM 11953, Candida glabrata 
DSM 11226, Cryptococcus neoformans DMS 11959, Cryptococcus neoformans DSM 6972, 
Microsporum canis DSM 10708, Trichophyton mentagrophytes DMS 4870, Trichophyton rubrum 
DMS4167; Data represent the mean of three separate experiments in triplicate. 
 
 
 
 Untreated roots Chitosan-treated roots Fluconazole 
 MIC ( µg mL-1) 
Strains 
(number) 
MICa S
Db 
Rang
e 
MIC100c 
MICa S
Db 
Rang
e 
MIC100c 
MICa S
Db 
Rang
e 
MIC100c 
Candida 
albicans 
 (16) 
61.8 42.3 8-64 129.3 50.2 41.3 27.2 16-64 
110.7 57.
5 
1.5 2.3 
0.125-
8 
88.9 99.
1 
Candida 
krusei 
 (4) 
42.7 42.2 
16-
128 
128 125 13.3 7.1 8-32 85.3 56.8 8.7 6.7 
0.125-
16 
224 59.
2 
Candida 
glabrata  
(4) 
50.7 16.5 32-64 101.3 57.6 28 7.2 16-32 80 28.9 6.2 5 0.5-16 
104 74.
1 
Candida 
parapsilosis 
 (4) 
56.5 66.5 
16-
256 
104.5 95.6 33.1 17.6 
16-
256 
66.1 43.6 1.1 0.8 
0.125-
2 
5.4 4 
Candida  
tropicalis 
 (2) 
109.7 71.
2 
64-
256 
237.7 136.
8 
68.6 28.8 
32-
128 
132.6 65.
1 
1.2 0.2 1-2 
128 90.
5 
Cryptococcus   
neoformans 
 (12) 
37.3 12.3 32-64 106.7 32 26.7 7.8 16-32 96 32.9 1.7 1.2 0.5-4 
17.5 19.
5 
Trichophyton  
mentagrophyt
es 
 (6) 
74.7 24.9 
64-
128 
96 33.4 41.3 17.4 16-64 74.7 24.9 9.7 5.8 4-16 
27.3 19.
7 
Trichophyton 
rubrum 
 (2) 
64 0 64 128 0 64 0 64 64 0 1 0 1 16 0 
Microsporum 
gypseum 
(4) 
96 35 
64-
128 
96 35 90.7 42.5 
32-
128 
117.3 74.
8 
21.33 8.2
6 
16-32 80 52.6 
Microsporum 
canis 
 (2) 
64 0 64 128 0 64 0 64 128 0 6 2.82 4-8 12 5.6 
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To improve the efficiency of this system, we performed new 
experiments, taking into account that in vitro organ growth and 
secondary metabolite production are often governed by different 
combinations of growth regulators and that secondary plant metabolism 
is generally stimulated when cell growth is slowed [11]. These 
considerations led us to develop a new three-step culture system. The 
first step consisted of culturing roots in Medium 1, which contained 
indole butyric acid (IBA) as auxin, in order to obtain a consistent 
amount of root biomass. The second step consisted of subculturing 
roots in Medium 2, which contained 1-naphthalenacetic acid (NAA), 2,4-
dichlorophenoxyacetic acid (2,4-D) and kinetin, used to increase 
secondary metabolite production. Previous studies have shown that 
NAA stimulated xanthone accumulation in cell suspension cultures of 
Hypericum perforatum [12,13]. In H. perforatum subsp. angustifolium root 
cultures, the positive effect of the combined growth regulators (Medium 
2) on both xanthone production and antifungal activity is reported for 
the first time in the present study. The results demonstrate that the roots 
transferred to Medium 2 had 3.53 times higher xanthone production and 
from 5 to 10 times higher antifungal activity against Candida spp., C. 
neoformans, and  dermatophytes, with the respect to the roots maintained 
in Medium 1 (Table 2). Regarding the third step, the addition of chitosan 
led to a further increase in both total xanthone content and antifungal 
activity, in particular against Candida spp. (Table 3), confirming that 
chitosan is an effective elicitor in this in vitro system. The decrease in 
xanthone accumulation, observed after 15 days of culture, in the medium 
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supplemented with chitosan (Table 1), could be explained as a 
deterioration of the xanthones previously produced. 
The extracts showed low cytotoxicity against mammalian cells. In 
conclusion, this three-step culture of Hypericum perforatum roots could be 
a good system to obtain extracts for treating human fungal infections.  
 
4. Materials and methods  
4.1 Plant material and tissue culture 
Regenerated roots of H. perforatum subsp. angustifolium (sin. Fröhlich) 
Borkh were cultured in a three-step-system. In the first step, the roots 
were cultured for 23 days in half-strength liquid MS medium 
supplemented with 1 mg L-1 IBA and 1.5% (w/v) sucrose (herein 
referred to as “Medium 1.”). In the second step, to stimulate secondary 
metabolite production, the roots were transferred from Medium 1 to 
half-strength liquid MS medium supplemented with 1.1 mg L-1 2,4-D, 
0.215 mg L-1 KIN, and 0.186 mg L-1 NAA (referred to as “Medium 2”)  
and cultured for 23 days. For both Media 1 and 2, liquid cultures were 
established by inoculating 5 g fresh weight of the roots, corresponding to 
0.5 g dry weight (DW), in 250-mL Erlenmeyer flasks containing 100 mL. 
The flasks were shaken at 100 rpm at 25±1°C and maintained in the 
dark.  
In the third step, the roots were subcultured again in Medium 2; after 
8 days, some of the roots were treated with chitosan (medium molecular 
weight, Sigma-Aldrich, Italy) at a final concentration of 200 mg L-1. 
Samples of roots during the third step were harvested by filtration on 
days 0, 8, 11, 15, 18 and 23 to perform extraction and chemical analysis. 
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To compare Medium 1 and Medium 2 in terms of antifungal activity, 
some of the roots were maintained in Medium 1, subculturing them 
every 23 days. 
4.2 Determination of root biomass 
For both Medium 1 and Medium 2, root biomass was determined at 
the end of culture by recording the dry weight (DW). The roots were 
separated from the medium by passing them through a stainless steel 
sieve and washed with distilled water to remove residual medium. They 
were then dried in an oven at 40°C for 72 h, and the DW was measured. 
The growth index was calculated as follows: 
 
 
“Initial dry weight” indicates the weight of the roots before extraction, 
and “final dry weight” indicates the weight of roots after extraction with 
methanol. 
4.3 HPLC analysis 
After exsiccation, the roots were grinded and extracted three times 
with methanol. The obtained extracts were evaporated to dryness in a 
rotary evaporator at 40 °C  and dissolved in methanol to be analyzed as 
previously described [9] using an HPLC apparatus consisting of a pump 
(Waters 1525 Binary HPLC Pump), equipped with a UV detector 
(Waters 2487 Dual λ Detector) and a reverse phase C18 column (4.6 mm 
x 150 mm; 5 µm; Waters).  The extract composition was determined by 
linear gradient elution, using a modified version of the method of Dias et 
al. [14]. The mobile phase was a gradient prepared from 100:0.1 (v/v) 
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water–phosphoric acid (Component A) and methanol (Component B) 
(Carlo Erba, Milan, Italy); the gradient was from 10% to 50% 
Component B in 13 min, holding for 10 min, and then from 50% to 
95% Component B in 42 min. The injection volume was 20 μL; the 
mobile phase flow rate was 1.0 mL min-1. The compounds were 
identified at 260 nm and 320 nm by the external standard method, using, 
as reference, xanthones previously purified and spectroscopically 
characterized in our laboratory (1,3,6,7-tetrahydroxyxanthone, 1,3,5,6-
tetrahydroxyxanthone, toxyloxanthone B, paxanthone, and cadensin G) 
[15] 1,7-dihydroxyxanthone and 5-methoxy-2-deprenylrheediaxanthone 
B were purified from in vitro regenerated roots of H. perforatum subsp. 
angustifolium [10]. Xanthones were quantified as paxanthone equivalents 
at 260 nm. 
4.4 Organisms 
For the antifungal evaluation, strains obtained from the American 
Type Culture Collection (ATCC, Rockville, MD, USA), the German 
Collection of Microorganisms (DSMZ, Braunschweig, Germany) and the 
Pharmaceutical Microbiology Culture Collection (PMC, Department of 
Public Health and Infectious Diseases, Sapienza, Rome, Italy) were 
tested. The strains obtained from the ATCC were Candida albicans 
[ATCC90028, ATCC90029, ATCC10261, ATCC10231, ATCC3153, 
ATCC2091, ATCC76615, ATCC24433 (tested as reference strain)], 
Candida parapsilosis ATCC22019 (tested as quality control strain), and 
Trichophyton mentagrophytes ATCC9972 (tested as reference strain). The 
strains obtained from the DSMZ were C. parapsilosis (DSM11224, 
DSM5784), Candida krusei DSM6128, Candida tropicalis DSM11953, 
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Candida glabrata DSM11226, Cryptococcus neoformans (DSM 11959, 
DSM6972), T. mentagrophytes DSM4870, Trichophyton rubrum DSM4167, 
Microsporum canis DSM 10708, and Microsporum gypseum DSM 3824. The 
strains obtained from PMC were C. albicans (PMC 1011, PMC 1015, 
PMC 1023, PMC 1071, PMC 1075, PMC 1083, PMC 1088, PMC 1097), 
C. parapsilosis (PMC 0703, PMC 0711), C. tropicalis PMC 0908, C. krusei 
(PMC 0613, PMC 0625, PMC 0639), C. glabrata (PMC 0805, PMC 0821, 
PMC 0843), C. neoformans (PMC 2103, PMC2107, PMC 2111, PMC 2123, 
PMC 2136, PMC 2138, PMC 2142, PMC 2157, PMC 2169, PMC 2185), 
T. mentagrophytes (PMC 6503, PMC 6509, PMC 6515, PMC 6527, PMC 
6531, PMC 6552), T. rubrum PMC 6612, M. gypseum (PMC 7303, PMC 
7331, PMC 7342), and M. canis PMC 7426. All of the strains were stored 
and grown in accordance with the procedures of the Clinical and 
Laboratory Standards Institute (CLSI) [16,17]. 
4.5 Antifungal susceptibility assays 
In vitro antifungal susceptibility was evaluated both for the total 
extracts of the roots grown in Medium 2, collected on day 15 of the third 
step, treated and untreated with chitosan, and for the extracts obtained 
from roots maintained in Medium 1, using the CLSI broth microdilution 
methods [16,17]. 
The antifungal reference fluconazole (Sigma-Aldrich, St. Louis, 
Missouri, U.S.A.) was also tested. The final concentration ranged from 
0.0078 to 250 µg mL-1 for fluconazole and from 1 to 1000 µg mL1 for 
total dry root extracts. The extracts and fluconazole were dissolved 
previously in dimethyl sulfoxide  at concentrations 100 times higher than 
the highest desidered test concentration and successively diluted in test 
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medium in accordance with the procedures of the CLSI [16]. 
Microdilution trays containing 100 µL of serial two-fold dilutions of 
fluconazole or of root extracts in RPMI 1640 medium (Sigma-Aldrich, 
St. Louis, Missouri, U.S.A) were inoculated with an organism suspension 
adjusted to attain a final inoculum concentration of 1.0 x 103 - 1.5 x103 
cells mL-1 for yeasts and 0.4x104 - 5x104 CFU mL-1 for dermatophytes. 
The panels were incubated at 35°C and observed for the presence of 
growth at 48 h (Candida spp.) and 72 h (C. neoformans and 
dermatophytes). 
Quality control was performed by testing the CLSI-recommended 
strain C. parapsilosis ATCC 22019 [18].The minimal inhibitory 
concentration (MIC) was defined as, for yeasts, the lowest concentration 
that showed ≥50% growth inhibition compared with the growth control 
and, for dermatophytes, the lowest concentration that showed ≥80% 
growth inhibition compared with the control. The MIC100 (i.e., 100% 
growth inhibition) was also evaluated for all of the substances. All of the 
experiments were performed in triplicate on three consecutive test days. 
4.6 Cell viability assay 
The cytotoxicity of total extracts used for antifungal assays was 
evaluated on Madin-Darby canine kidney cells (MDCK) and Human 
cervix carcinoma cells (HeLa) obtained from the ATCC (Rockville, MD, 
USA) by MTT assay (Sigma-Aldrich, St. Louis, MO, USA) [18]. The cells 
(2x104 cells well-1) were seeded into 96-well plates containing 100µL of 
RPMI 1640 (Invitrogen, San Diego, CA, USA) without phenol red, 
supplemented with 10% fetal bovine serum (Invitrogen, San Diego, CA, 
USA), L-glutamine (0.3mg ml-1), penicillin (100U ml-1), and streptomycin 
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(100µg ml-1) (EuroClone, Celbio, Milan, Italy). The cells were cultured at 
37°C in 5% CO2. Total extracts, with concentrations ranging from 32 to 
500 µg mL-1, were added to the wells. Each concentration and control 
was tested in four replicates with at least five concentrations. The cells 
were cultured at 37°C in 5% CO2 for 24 h. MTT solution was added to 
each well and the plates were incubated for 3-4 h at 37°C in 5 % CO2. 
MTT solvent (Sigma-Aldrich, St. Louis, MO, USA) was added to 
dissolve the intracellular crystal. The plates were then incubated at 37°C 
in 5% CO2 for 1 h, and the optical density of each well was measured 
spectrophotometrically at 570 nm. The cytotoxicity of the root extracts 
was calculated as the percentage reduction in viable cells with respect to 
the control culture. The 50% cytotoxic concentration (CC50) was 
evaluated as the drug concentration required to reduce human cell 
viability by 50% compared to the drug-free control. 
4.7 Statistical analysis 
The arithmetic mean and standard deviation (SD) were calculated. 
Data were analyzed by Student‟s t test for significance. P values of <0.05 
were considered as significant; P values of <0.001 were considered as 
highly significant. 
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Chapter 8: 
Effect of water-soluble chitosan derivatives on 
xanthone production in H. perforatum subsp. 
angustifolium root cultures  
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Chitosan proved to be an enhancer of xanthone production in Hypericum 
perforatum root cultures.  In spite of the chitosan efficacy, the poor 
solubility in water of chitosan is the major limiting factor in its utilization 
in large scale production systems. The semisynthetic carboxymethyl-
chitosan is a water soluble chitosan derivative. With the aim to optimize 
the condtions for the scale up process of root cultures, the effect of 
carboxymethylchitosan and its derivatives on xanthone production and 
on the antifungal activity of the root extracts deriving from the 
treatments has been studied.  
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Abstract 
The aim of this study was to individuate, by  bioassay-guided 
fractionation,  promising antifungal fractions and/or constituents from 
Hypericum perforatum subps. angustifolium in vitro roots. Treatments with O-
carboxymethylchitosan (CMC) and its derivatives were used to improve 
xanthone production in the roots. The bioassay-guided fractionation of 
CMC-treated roots led to the individuation of a ethylacetate fraction, 
containing the highest amount of xanthones (6.8%) and showing the 
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best antifungal activity with MIC values of 53.82, 14.18, and 36.52 
µg/ml, against Candida spp, C. neoformans and dermatophytes, 
respectively. From this fraction the prenylated xanthone, biyouxanthone 
D has been isolated and represented the 44.59% of all xanthones 
detected. For the first time in the present paper biyouxanthone D has 
been found in H. perforatum roots and tested against C. neoformans, 
dermatophytes, and Candida species. The xanthones showed the greatest 
antifungal activity against C. neoformans and dermatophytes, with MIC 
values of 20.16, 22.63 µg/ml. In conclusion, the results obtained in the 
present study demonstrated that CMC-treated Hpa in vitro root extracts 
represent a tool for the obtainment of promising candidates for further 
pharmacological and clinical studies. 
 
Graphical abstract 
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Introduction 
The past few decades have been characterized by a worldwide increase in 
the incidence of fungal infections (candidiasis and other fungal diseases). 
The majority of clinically used antifungals show disadvantages such as 
undesirable side effects or rapid development of resistance and, as a 
consequence, new antifungal agents are needed to improve the antifungal 
therapy (Malheiros et al., 2005). This has led to search for therapeutic 
alternatives among natural compounds. Phytochemical content of wild 
grown plants is subjected to variation and is influenced by environmental 
conditions. In vitro cultures, guarantee both the growth of plant biomass 
under controlled conditions and the obtainment of extracts standardized 
in chemical composition.   
Standardized xanthone-rich extracts from in vitro regenerated Hypericum 
perforatum subps. angustifolium (Hpa) showed interesting antifungal activity 
against human pathogen fungi (Candida species, Cryptococcus neoformans, 
dermatophytes) (Tocci et al., 2011 and 2012). It was observed that the 
antifungal activity was positively correlated with the xanthone 
concentration of the Hpa in vitro root extracts. The treatment of roots 
with chitosan, in fact, stimulated xanthone biosynthesis and in parallel 
improved the antifungal activity of the extracts (Tocci et al., 2011 and 
2012). Chitosan is a linear aminopolysaccharide of glucosamine and N-
acetylglucosamine units largely used in various industrial countries. 
Chitosan exerts antimicrobial activity and is able to induce host defense 
responses in both monocotyledons and dicotyledons. It has been shown 
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that chitosan induces the production of glucanohydrolases, phenolic 
compounds and synthesis of specific phytoalexins with antifungal 
activity (Bautista-Banhos et al., 2006). In spite of the chitosan 
advantages, the poor solubility, low surface area, and porosity of 
chitosan are the major limiting factors in its utilization for applicative 
purposes. Chemical modifications of chitosan are increasingly studied for 
the potential of providing new applications.  
In the present study the effect of O-carboxymethylchitosan (CMC) and 
its derivatives on xanthone production from Hpa in vitro regenerated 
roots has been evaluated. CMC is a water-soluble chitosan derivative, 
which has been widely studied because it is easily synthesized, 
ampholytic character and possibilities of numerous applications and very 
low toxicity (Mourya et al., 2010; De Oliveira et al., 2012). CMC has 
been modiﬁed by introducing alkyl (hexanoyl anhydride, linoleic acid) or 
acyl groups (substituted benzaldehydes) in order to increase solubility in 
water and organic solvents (Yin et al., 2012; Rosa et al., 2011, Wiarachai 
et al., 2012). Moreover the aim of the present study was to individuate, 
by bioassay-guided fractionation, fractions and constituents of Hpa in 
vitro root extracts showing antifungal activity against human fungal 
pathogens. 
Materials and Methods 
Plant material  
In vitro regenerated roots of Hpa were obtained as described by Tocci et 
al., 2011 and cultured in half strength MS medium (Murashige and 
Skooge, 1964) supplemented with 1 mg/g indolbutyric acid (IBA) and 
1.5% (w/v) sucrose for 23 days according to the growth curve. Liquid 
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cultures were established by inoculating 5 g fresh weight of the roots, 
corresponding to 0.5 g dry weight (DW), in 250ml Erlenmeyer flasks 
containing 100 ml. The flasks were shaken at 100 rpm at 25 °C and 
maintained in the dark. 
Synthesis of O-carboxymethylchitosan  
Chitosan (Mw 265 g/mol, deacetylation degree 80%) was obtained from 
Purifarma, Brazil. All the reagents used were of analytical reagent quality, 
purchased from Vetec, Brazil. O-carboxymethylchitosan (CMC) was 
prepared by a modification of the method described by Chen and Park 
(2003). In brief, 10 g of chitosan were suspended in 100 ml of a solution 
containing 13.5 g of sodium hydroxide, 80 ml of water, and 20 ml of 2-
propanol, at 5 oC and stirred for 2 h. Monochloroacetic acid (15 g) was 
dissolved in 2-propanol (25 ml) and added dropwise to the alkalized 
chitosan. The reaction was stopped by adding 70% (v/v) ethyl alcohol 
(200 ml)  and led to the obtainment of O-carboxymethylchitosan with  a 
degree of carboxymethylation of 44.3% (determined by conductometric 
titration). 
Synthesis of O-carboxymethylchitosan amphiphilic derivatives 
OCCh (5 g) was dispersed into a solution made of 300 ml water and one 
equivalent of aldehyde (benzaldehyde-, 4-methoxybenzaldehyde, 4-
hydroxybenzaldehyde and 4-N,N-dimethylaminobenzaldehyde) and 
methanol at pH 4. After 1 day stirring, NaBH4 was added and the 
mixture was stirred for 1.5 hour. The derivatives were precipitated by 
adding acetone and dried in vacuum for 24 h as described by Rabea et 
al., 2005. 
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The 1H NMR analysis was performed using a Bruker Nuclear Magnetic 
Resonance 300 MHz Spectrometer and the polymers were dispersed in 
CD3COOD and D2O. 
The reactions between O-CMCh and benzaldehyde, 4-
methoxybenzaldehyde, 4-hydroxybenzaldehyde and 4-N,N-
dimethylaminobenzaldehyde, resulted in the following derivatives: N-
benzyl-O-carboxymethylchitosan (BzCMC), N-(4-methoxybenzyl)-O-
carboxymethylchitosan (N,O-CMC), N-(4-hydroxybenzyl)-O-
carboxymethylchitosan (OHCMC), N-(4-N,N-dimethylaminobenzyl)-O-
carboxymethylchitosan (N,N-CMC).  
Elicitation treatments 
The elicitation treatments with different chitosans, were performed 
according to the protocol previously established and optimized by the 
authors (Tocci et al., 2011).  The elicitors were added at the 8th day of 
culture at the final concentration of 200 mg/l. Samples of roots were 
harvested after 8 days of treatment by filtration and subjected to 
extraction and chemical analysis. 
Root extraction and HPLC analysis 
After drying, the roots were grinded and subjected to extraction. All the 
solvents used were purchased by Carlo Erba Reagents, Italy. Samples of 
roots treated and untreated were extracted three times with methanol. 
Roots treated with CMC were subjected also to serial extractions with 
solvent of increasing polarity. The first extraction was performed with 
chloroform, then roots were left to dry, in order to eliminate any trace of 
chloroform, and extracted with ethyl acetate and finally with methanol. 
The obtained extracts were evaporated to dryness in a rotary evaporator 
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at 40 °C. The extracts were dissolved in methanol (HPLC grade, Carlo 
Erba Reagents, Italy) and filtered with syringe filter, pore sizes 0.45µm, 
to remove insoluble particles which could negatively affect the 
chromatographic separation performance. HPLC analysis were carried 
out as described by Tocci et al. 2010, using the elution method reported 
by Dias et al. 1999 with little modifications. Briefly the mobile phase was 
a gradient prepared from 100:0.1 (v/v) water–phosphoric acid 
(component A) and methanol (component B); the gradient program was 
from 10% to 50% B in 13 min, holding for 10 min, and then from 50% 
to 95% B in 42 min. The injection volume was 20 μl, the mobile phase 
flow rate was 1.0 ml/min. The compounds were identified at 260 nm 
and 320 nm by the external standard method, using, as reference, 
xanthones that had been previously purified and spectroscopically 
characterized in our laboratory (1,3,6,7-tetrahydroxyxanthone, 1,3,5,6-
tetrahydroxyxanthone, toxyloxanthone B, paxanthone, and cadensin G). 
1,7-dihydroxyxanthone and 5-methoxy-2-deprenylrheediaxanthone B 
were purified from in vitro regenerated roots of HPA (Tocci et al., 2011). 
Xanthones were quantified as paxanthone equivalents at 260 nm. 
Isolation of biyouxanthone D 
Biyouxanthone D was isolated by preparative thin layer chromatophy 
(silica gel, hexane/ethyl acetate 1:1) (Carlo Erba, Italy) from the 
ethylacetate extract of CMC-treated roots. The identification was carried 
out by nuclear magnetic resonance (NMR). Spectroscopic data were 
recorded at room temperature on an Avance 400 MHz NMR 
spectrometer. The identification was carried out by nuclear magnetic 
resonance (NMR) spectroscopy. Monodimensional 1H and 13C 
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experiments as well as bidimensional homonuclear 1H-1H TOCSY and 
bidimensional heteronuclear 1H-13C HSQC experiments were recorded 
at a temperature of 298 K on an Avance 400 MHz NMR spectrometer 
employing the pulse sequences present in the spectrometer routines. The 
univocal resonance was assigned  on the basis of TOCSY and HSQC 
scalar couplings while the identification of quaternary carbons was 
obtained comparing the 13C NMR chemical shifts (δ) with those of 
literature data and the results are reported in Table 1. 
Organisms 
For the antifungal evaluation, strains obtained from the American Type 
Culture Collection (ATCC, Rockville, MD, USA), the German 
Collection of Microorganisms (DSMZ, Braunschweig, Germany) and the 
Pharmaceutical Microbiology Culture Collection (PMC, Department of 
Public Health and Infectious Diseases, “Sapienza” University, Rome, 
Italy) were tested. The strains were: Candida albicans (ATCC 10231, 
ATCC 10261, ATCC 24433, ATCC 90028, ATCC 90029, PMC 1002, 
PMC 1016, and 1093), C. parapsilosis ATCC22019, C. parapsilosis PMC 
0703, C. tropicalis DSM 11953, C. tropicalis PMC 0908,  C. glabrata PMC 
0805, C. glabrata PMC 0823, C. krusei DSM 6128, and C. krusei PMC 
0625), Cryptococcus neoformans (DSM 11959, PMC 2136, PMC 2123, PMC 
2115, PMC 2103, PMC 2107, PMC 2102, and PMC 2111), 
dermatophytes (Trichophyton mentagrophytes DSM 4870, T. mentagrophytes 
PMC 6503, T. mentagrophytes PMC 6509, T. mentagrophytes PMC 6552, 
Trichophyton rubrum PMC 6612, Microsporum gypseum DSM 3824, and M. 
gypseum  PMC 7331). All of the strains were stored and grown in 
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accordance with the procedures of the Clinical and Laboratory Standards 
Institute (CLSI) (CLSI, 2008a, b). 
Antifungal susceptibility assays 
In vitro antifungal susceptibility was evaluated for the extracts from root 
cultures  and isolated biyouxanthone D, using the CLSI broth 
microdilution methods (CLSI,2008a, b). Fluconazole (FLC) was used as 
reference drug. The final concentration ranged from 1 to 512 µg/ml for 
total dry root extracts and from 0.125 to 64 µg/ml for Biyouxanthone D 
and for FLC. The extracts were dissolved previously in dimethyl 
sulfoxide at concentrations 100 times higher than the highest desired test 
concentration and successively diluted in test medium in accordance with 
the procedures of the CLSI (CLSI, 2008c). Microdilution trays 
containing 100 µl of serial two-fold dilutions of root extracts in RPMI 
1640 medium (Sigma-Aldrich, St. Louis, Missouri, U.S.A) were 
inoculated with an organism suspension adjusted to attain a final 
inoculum concentration of 1.0 x 103 - 1.5 x103 cells/ml for yeasts and 
0.4x104 - 5x104 CFU/ml for dermatophytes. The panels were incubated 
at 35°C and observed for the presence of growth at 48 h (Candida spp.) 
and 72 h (C. neoformans and dermatophytes). 
The minimal inhibitory concentration (MIC) defined as, for yeasts, the 
lowest concentration that showed ≥50% growth inhibition compared 
with the growth control and, for dermatophytes, the lowest 
concentration that showed ≥80% growth inhibition compared with the 
growth control was evaluated for all extracts and biyouxanthone D.  The 
results were expressed as  the median of the MIC values of five 
 139 
 
replicates, and the  geometric mean (GM) and the range of the MIC 
values.  
Results  
1H NMR analysis of CMC and its derivatives 
The 1H NMR spectra of the derivatives showed the characteristic O-
CMCh signal, a signal at approximately 7.0 ppm indicating the presence 
of an aromatic group (benzene ring), and the following peaks: singlet at 
3.7 ppm (methoxy group protons) for 4-CH3O-BzCMCh, singlet at 7.1 
ppm (phenolic hydroxyl group) for 4-OH-BzCMCh, and singlet at 3.1 
ppm (two methyl groups binded to nitrogen on the benzene ring) for 4-
N,N-(CH3)2BzCMCh respectively. The SD of the derivatives varies 
according to the aldehyde and the methodology employed. The SD 
values were 12 %, 3 %, 27% and 65 %, for BzCMCh, 4-CH3O-
BzCMCh, 4-OH-BzCMCh, 4-N,N-(CH3)2BzCMCh respectively. 
Bioassay-guided isolation and identification of antifungal compounds  
The antifungal activity of total root extracts from root cultures treated 
with BzCMC and CMC, which at a first analytical screening showed to 
be the richest in xanthones (Table 1), has been evaluated against Candida 
species, C. neoformans, and dermatophytes.  
The extract from roots treated with BzCMC showed the geometric mean 
MIC values of 89.21 µg/ml for Candida species (Table 2), 49.15 µg/ml 
for dermatophytes (Table 3) and 27.52 µg/ml for C. neoformans (Table 4). 
In line with the higher amount of  xanthones in the extract from root 
cultures  treated with CMC, an improved antifungal activity has been 
found. This extract in fact showed an increase of antifungal activity 
 140 
 
against all tested fungi, with MIC values of 40.90, 33.07, and 13.76 
µg/ml, for Candida species, dermatophytes and C. neoformans, respectively.  
 
Table 1: Xanthones in H. perforatum subsp. angustifolium roots after treatment with CMC 
and its derivatives. 
 
Xanthones 
Control Chitosan CMC BzCMC OHCMC 
N,N-
C
M
C 
(mg/g DW) 
1,3,5,6-; 1,3,6,7-
tetrahydroxyxanthone  
0.37±0.01 1.2±0.04 5.7±0.13 2.8±0.21 0.54±0.02 0.18±0.02 
1,7-dihydroxyxanthone  1.66±0.04 8.36±0.39 4±0.36 0.8±0.05 2.23±0.14 0.45±0.01 
Toxyloxanthone B 0.35±0.01 2.48±0.12 3.8±0.26 1.99±0.07 0.18±0.02 nd 
Paxanthone  0.53±0.02 1.44±0.05 11.92±0.59 2.71±0.12 1.3±0.15 0.61±0.03 
5-O-methyl-2-
deprenylrheediaxanthone B 
0.73±0.03 0.78±0.02 0.98±0.05 0.78±0.04 0.75±0.05 1.72±0.14 
Biyouxanthone D 0.25±0.01 2.23±0.15 16.02±0.68 4.48±0.16 3.29±0.15 4.5±0.52 
Total  3.89±0.21 16.49±0.77 42.42±2.07 13.56±0.65 8.29±1.18 7.46±0.72 
 
CMC-treated roots were therefore subjected to bioassay-guided 
fractionation to isolate and identify antifungal constituents (Table 5).  
The antifungal activity of three fractions obtained by extraction with 
chloroform, ethyl acetate and methanol has been evaluated. The 
ethylacetate fraction showed the greatest activity against Candida species 
(Table 2), dermatophytes (Table 3) and C. neoformans (Table 4) among the 
other tested ones, with MIC values of 53.82, 36.52, and 14.18 µg/ml, 
respectively. The HPLC qualitative analysis of the ethylacetate fraction 
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showed the presence of one unidentified major peak with retention time 
of 56 minutes, among the others obtained from CMC-treated Hpa root.  
 
Table 2: Antifungal activity against Candida species of root extracts  
 
MIC: the lowest concentration that showed ≥50% growth inhibition compared with the 
growth control GM:  Geometric mean of the minimal inhibitory.The MIC results were 
expressed as median  
 
The unkown compound was isolated and purificated by preparative 
TLC. The process led to the obtainment of 7 mg of compound which 
 CMC BzCMC  EtAc CHCl3 MeOH Fluconazole 
Candida species MIC( µg/ml)  
C. albicans PMC1002 64 128 64 64 64 0,25 
C.albicans ATCC 3153 32 128 32 64 64 16 
C.albicans ATCC 10231 64 128 64 128 128 2 
C.albicans ATCC 10261 32 64 64 128 64 4 
C.albicans ATCC 90028 32 64 32 64 128 0,50 
C.albicans ATCC 24433 64 128 64 64 64 1 
C.albicans ATCC 90029 32 128 64 128 64 0,25 
C.albicans PMC 1016 64 64 128 128 64 0,25 
C.parapsilosis DSM 5784 32 128 128 128 128 1 
C.parapsilosis PMC 0703 64 128 128 128 128 0,25 
C.tropicalis DSM11953 64 128 64 128 128 1 
C.tropicalis PMC 0908 64 128 32 64 128 1 
C.glabrata PMC 0805 32 64 64 128 64 1 
C.glabrata PMC 0823 32 64 64 128 64 1 
C.krusei DSM 6128 32 64 16 32 64 16 
C.krusei PMC 0625 16 32 16 64 128 16 
GM 40.90 89.21 53.82 95.89 97.29 1.23 
RANGE 16-64 32-128 16-128 32-128 64-128 0.25-32 
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was characterized by 1HNMR (Table 6)  and identified as biyouxanthone 
D by comparison with literature data (Tanaka et al., 2010). 
Biyouxanthone D was quantified in all the studied extracts and revealed 
to be the major xanthone (tables 1 and 5). In particular the amount of 
biyouxanthone D detected in the total extract was very similar to the one 
detected in the ethylacetate fraction (Table 2). Biyouxanthone D, showed 
high antifungal activity against dermatophytes and C. neoformans with 
MIC values of  22.63 and 20.16, while higher MIC values were observed 
for Candida spp (data not shown). 
 
Table 3: Antifungal activity against dermatophytes of root extracts obtained from CMC-
treated Hpa roots  
Dermatophytes 
MIC( µg/ml) 
 
CMC BzCMC  EtAc CHCl3 MeOH Fluconazole 
Trichophyton mentagrophytes DSM 4870 64 64 64 64 64 
16 
Trichophyton mentagrophytes PMC 6509 32 64 32 64 128 
1 
Trichophyton mentagrophytes PMC 6552 32 32 32 64 128 
16 
Trichophyton mentagrophytes PMC 6503 32 64 64 64 128 
2 
Microsporum gypseum PMC 7303 64 64 32 32 64 
16 
Trichophyton rubrum PMC 6612 32 64 32 64 64 
2 
Microsporum gypseum DSM 3824 16 16 32 32 64 
16 
GM 33.07 49.15 36.52 52.50 98.29 5.56 
range 16-64 16-128 16-128 16-128 32-512 1-16 
MIC: the lowest concentration that showed ≥80% growth inhibition compared with the 
growth control.GM:  Geometric mean of the minimal inhibitory.The MIC results were 
expressed as median.  
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Table 4: Antifungal activity against Cryptococcus neoformans of root extracts obtained from 
CMC-treated Hpa roots  
 
Cryptococcus neoformans 
 MIC( µg/ml) 
 CMC BzCMC  EtAc CHCl3 MeOH Fluconazole 
PMC 2111 32 64 16 16 32 1 
PMC 2115 32 64 32 32 32 4 
PMC 2102 32 32 16 32 64 4 
PMC 2103 16 8 16 16 32 2 
PMC 2107 16 64 16 32 64 1 
DSM 11959 8 16 8 8 16 2 
PMC 2123 16 32 16 16 32 2 
PMC 2136 4 32 8 16 16 2 
GM 13.76 27.52 14.18 19.76 32.98 2.06 
RANGE 4-32 8-64 8-32 8-64 16-64 1-4 
MIC: the lowest concentration that showed ≥50% growth inhibition compared with the 
growth control.GM:  Geometric mean of the minimal inhibitory. The MIC results were 
expressed as median.  
 
 
Xanthone production in roots after treatments  
In all of the analyzed treated samples an increased amount of xanthones 
was detected (table 1). The composition of the extracts was qualitatively 
similar but characterized by different concentration of the each of the 
xanthones. CMC was found to be the best elicitor for xanthones, 
inducing 10.90 folds the amount detected in the control (42.42 and 3.89 
mg/g DW respectively), followed by BzCMC (3.48 folds), OHCMC 
(2.13 folds) and N,NCMC (1.91 folds). The composition of the extracts 
differed in the concentration of the xanthones. In a previous work we 
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found that in chitosan-treated roots, 1,7-dihydroxyxanthone was the 
main compound accumulated, followed by the toxyloxanthone B (table 
1). 
 
Table 5: Xanthones from CMC-treated roots obtained with extraction with different 
solvents  
Xanthones 
Total extract CHCl3 EtAc MeOH 
% 
mg/g 
DW 
% 
mg/g 
DW 
% 
mg/g 
DW 
% 
mg/g 
DW 
1,3,5,6-; 1,3,6,7-Tetraoxyxanthone  1.8 5.7 Nd Nd 0.6 0.37 0.69 2.2 
1,7-dihydroxyxanthone  1.2 4 0.07 0.051 2.53 1.55 1.37 4.36 
Toxyloxanthone B 1.2 3.8 0.19 0.15 1.03 0.63 0.3 0.96 
Paxanthone  3.77 11.92 0.4 0.3 1.6 1 0.6 1.9 
5-O-methyl-2-
deprenylrheediaxanthone B  
0.31 0.98 0.46 0.35 1.05 0.66 0.29 0.91 
Biyouxanthone D 5.07 16.02 1.01 0.77 5.48 3.45 0.58 1.82 
Total 13.35 42.42 2.13 1.62 12.29 7.66 3.83 12.16 
 
The roots treated with CMC and its derivatives accumulated 
biyouxanthone D as the major xanthone. In particular the CMC 
treatment induced the highest production of biyouxanthone D (16.02 
mg/g DW) among the analyzed samples. CMC- and BzCMC-treated 
roots accumulated paxanthone as the second major compound 
(11.92±1.02 and 2.71±0.06 mg/g DW respectively), while in OHCMC- 
and N,NCMC-treated roots accumulated 1,7-dihydroxyxanthone 
(2.23±0.04 mg/g DW) and 5-O-methyl-2-deprenylrheediaxanthone B 
(1.72±0.06 mg/g DW) were the second most produced compounds. 
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Figure 1: HPLC chromatographic profile at 260 nm of the ethyl acetate extract  of Hpa 
roots treated with CMC. Xanthones: ( X1, X2) 1,3,5,6-tetrahydroxyxanthone and 1,3,6,7-
tetrahydroxyxanthone, (X3) 1,7-dihydroxyxanthone, (X4) toxyloxanthone B, (X5) 
paxanthone, (X6) 5-O-methyl-2-deprenylrheediaxanthone B, (X7) biyouxanthone D. 
 
 
The extraction of CMC-treated with solvent of increasing polarity led to 
the obtainment of fractions different in composition (table 5). The 
fraction deriving from chloroform extraction led to an extract composed 
for 2.13% of xanthones, of which 1.01% represented by biyouxanthone 
D and 0.46% by 5-O-methyl-2-deprenylrheediaxanthone B, both the 
xanthones with less polarity among the detected ones.  
The extract obtained with ethylacetate was the richest in xanthones 
(12.28%) with a value very similar to the one calculated for total extract 
(13.35%) and was characterized by 5.48% biyouxanthone D and 1.6% 
paxanthone, followed by 1.05% 5-O-methyl-2-deprenylrheediaxanthone 
B and 1.03% toxyloxanthone B. The last fraction was obtained through  
extraction with methanol and was characterized by 3.83% xanthones, 
with 1.37% 1,7-dihydroxyxanthone and 0.58% biyouxanthone D.  
 
 
 146 
 
Table 6: 1H and 13C NMR resonance assignment of biyouxanthone D  
Position δ 1H multiplicity* (J Hz) Integral δ 13C 
7 6.91 d (8.9) 1 112.46 
8 7.69 d (8.9) 1 118.04 
4' 1.72 s 3 25.70 
5' 1.78 s 3 17.60 
1' 3.4 d (6.9) 2 21.36 
2' 5.23 m 1 121.00 
6'' 1.54 s 3 17.60 
10'' + 7'' 1.68 s 3 + 3 19.6 + 25.6 
3'' 2.12 m 2 31.67 
2'' 2.32 m (6.9) 1 47.57 
1'' 2.76 dd (6.9; 14.6) 1 26.95 
1'' 2.83 dd (6.9; 14.6) 1 26.95 
9'' 4.62 m 1 110.73 
9'' 4.68 m 1 110.73 
4'' 5.17 m 1 122.34 
1 \ \ \ 158.39 
2 \ \ \ 108.59 
3 \ \ \ 160.51 
4 \ \ \ 105.81 
4a \ \ \ 152.69 
5 \ \ \ 130.21 
6 \ \ \ 149.00 
8a \ \ \ 114.00 
9a \ \ \ 102.62 
9 \ \ \ 180.51 
10a \ \ \ 144.68 
3' \ \ \ 136.39 
5'' \ \ \ 133.79 
8'' \ \ \ 150.00 
*s: singlet; d: doublet; dd: double doublet;  m: multiplet; 
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Root cultures are an attractive biotechnological tool for the production 
of standardized extracts, and for the isolation of bioactive fractions and 
compounds (Pasqua et al 2005). The large-scale cultivation of 
untransformed roots for producing important phytochemicals has been 
achieved for medicinal plants such as Panax notoginseng (Gao et al. 2005), 
and Echinacea purpurea (Wu et al. 2007). In our previous works (Tocci et 
al., 2011 and 2012), we demonstrated that in vitro regenerated roots of H. 
perforatum produce higher xanthone amounts if compared with roots 
from wild grown plants and from in vitro grown plantlets (Tocci et al., 
under revision). Moreover, we proved a positive correlation between 
xanthone concentration in the extract and antifungal activity against 
human pathogen fungi. Previous experiments demonstrated that 
xanthone biosynthesis is sensitive to external stimuli. In particular 
chitosan and variation in growth regulators combination in the culture 
medium (Tocci et al., 2012) were able to influence the production of 
these compounds. This is not surprising in the light of the suggested role 
of xanthones in the plant. Franklin et al. (2009), in fact, in a study on 
phenolic metabolism in H. perforatum cell cultures, after infection with 
Agrobacterium tumefaciens, showed that xanthones act as phytoalexins and 
are produced as defense response to pathogen attack. Chitosan and its 
derivatives are known to form a semi-permeable film around plant 
tissues, they are inhibitory to a number of pathogenic fungi, and they 
also induce host-defense responses (El Ghaouth et al. 1994). CMC has 
shown to enhance chilling tolerance in cucumber seedlings (Sun et al., 
2004) and storage protein accumulation in maize seeds (Osuji et al., 
1992) and to delay powdery mildew disease in strawberry (Lowe et al., 
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2012). To our knowledge this is the first time that the CMC and its 
derivatives are used as elicitors of bioactive metabolites in H. perforatum. 
In all the analyzed treated samples it has been found that CMC 
derivatives stimulated the synthesis of xanthones (table 2). In 
comparison with the others, CMC- and BzCMC-treated roots were 
characterized by the highest amount of xanthones (42.42 ±2.13 and 
13.56±0.16 mg/g DW respectively) and among them the best antifungal 
activity was found for CMC-treated root extracts against all of the tested 
strains. The bioassay-guided fractionation of CMC-treated roots led to 
the individuation of a fraction, obtained by extraction with ethylacetate, 
containing the highest amount of xanthones (6.8%) and showing the 
best antifungal activity with MIC values of 53.82, 14.18, and 36.52, 
against Candida spp, C. neoformans and dermatophytes, respectively. Our 
results confirm the positive correlation between xanthone content in the 
extracts and antifungal activity as already observed in our previous 
studies (Tocci et al 2011 and 2012).  
The analysis of ethylacetate CMC-treated root extracts led to purification 
of a prenylated xanthone biyouxanthone D, isolated by Tanaka et al. 
(2010) from Hypericum chinense and for the first time in the present paper 
in H. perforatum roots. Biyouxanthone D represented the 44,59 % of all 
xanthones detected in ethylacetate  extract (table 3). The compound, 
tested for the first time in the present work against C. neoformans and 
dermatophytes showed interesting antifungal activity. Comparing the 
amount of biyouxanthone D in the tested extracts with the antifungal 
activity exerted, a linear positive correlation is evident, suggesting that 
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biyouxanthone D is an active constituent of the H. perforatum regenerated 
roots, against dermatophytes and C. neoformans. 
Little information is available on mechanism of action of xanthones as 
antifungals, recently Pinto et al (2011) reported that oxygenated 
xanthones reduced the biosynthesis of ergosterol. Moreover, it is 
important to underline that biyouxanthone D is a  prenylated compound. 
It is known that the presence of isoprenoid chains is a major determinant 
of the bioactivity which resides in a enhanced interaction with biological 
membranes and in an increased affinity for target proteins (Botta et al., 
2006). In conclusion, the results obtained in the present study 
demonstrated that CMC-treated Hpa in vitro root extracts represent a 
tool for the obtainment of promising candidates for further 
pharmacological and clinical studies in the developing formulations of 
new natural antifungal agents.  
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Chapter 10 
In vitro roots as a model system to investigate 
xanthone biosynthesis at a molecular level 
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The phytochemical analysis performed on wild grown plants showed 
that roots are accumulation oragns for xanthones. The in vitro studies 
demonstrated that roots are also organs where the synthesis takes place 
and that xathone biosynthesis can be stimulated by applying external 
stimuli.  Since nothing is known about the expression pattern at tissue or 
cell level of the gene econding Benzophenone Synthase, the key enzyme 
in xanthone biosynthesis, root cultures represent a good model system 
system for cloning and localization of benzophenone synthase 
transcripts in in vitro roots of Hypericum perforatum subsp. angustifolium. 
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Chapter 11 
Localization of xanthone biosynthesis at the 
transcript and protein levels in roots of Hypericum 
perforatum 
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Abstract 
Hypericum perforatum is widely used for medicinal purposes. Its classes of 
bioactive constituents involve xanthones, which are mainly accumulated 
in roots. The carbon skeleton of xanthones is formed by benzophenone 
synthase (BPS). A BPS cDNA was cloned from chitosan-treated root 
cultures of H. perforatum subsp. angustifolium and heterologously 
expressed. The molecular and kinetic properties of the recombinant 
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enzyme were studied. An antisense riboprobe was derived from the 
coding sequence and used for whole-mount  in situ hybridization. BPS 
transcripts were primarily localized to the first cortical cell layer and, to a 
lesser extent, to the endodermis. Antibodies against BPS were used for 
immunofluorescence localization of the enzyme protein in longitudinal 
and cross sections. Bright fluorescence was consistently observed in the 
apical meristem, the first cortical cell layer, and the endodermis, 
indicating cell-type specific biosynthesis of xanthones in H. perforatum 
roots.  
 
Key words: Hypericum perforatum, xanthones, benzophenone synthase, in 
situ hybridization, immunofluorescence localization. 
 
1. Introduction 
Hypericum perforatum L. (Hypericaceae) is a well-known medicinal plant 
widely used for the treatment of depression and skin disorders (Linde et 
al., 2008; Müller et al., 2008). The species is characterized by the 
presence of a number of bioactive constituents, which are derived from 
the polyketide metabolism (Beerhues, 2011). The major classes of active 
compounds are hypericins, hyperforins, flavonoids, and xanthones. The  
scaffolds of these metabolites are formed by type III polyketide synthase 
(PKS) enzymes, which are known to catalyze formation of a diversity of 
natural products by varying the starter substrate, the number of chain 
extension steps, and the mode of intramolecular cyclization (Austin and 
Noel, 2003). The PKS enzyme that is involved in formation of 
xanthones is benzophenone synthase (BPS; Liu et al., 2003). The enzyme 
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catalyzes the decarboxylative condensation of benzoyl-CoA with three 
molecules of malonyl-CoA to give 2,4,6-trihydroxybenzophenone, which 
then is converted to xanthones (Schmidt and Beerhues, 1997; Beerhues 
and Liu, 2009). BPS activity was first detected in Centaurium erythraea cell 
cultures (Beerhues, 1996). BPS cDNAs then were cloned from H. 
androsaemum and Garcinia mangostana and functionally expressed (Liu et al., 
2003; Nualkaew et al., 2012). Unlike hypericins, hyperforins, and 
flavonoids, which occur in the aerial parts of H. perforatum, xanthones are 
primarily present in the roots (Crockett et al., 2011; Tocci et al., 2012). 
Root cultures of H. perforatum subsp. angustifolium were found to produce 
particularly high amounts of xanthones, especially after treatment with 
chitosan (Tocci et al., 2010, 2011, 2012). Xanthone compounds exhibit a 
number of pharmacological activities (Fotie and Bohle, 2006).  
Little is known about the regulation of xanthone biosynthesis in roots, 
which is true for both the endogenous and the exogenous regulation. 
Here, chitosan-treated root cultures of H. perforatum subsp. angustifolium 
were used to clone a BPS cDNA, which was functionally expressed in 
Escherichia coli. The coding sequence served to derive a specific antisense 
probe, which was used for in situ hybridization. Furthermore, BPS 
antibodies were employed to localize the enzyme protein and to gain 
insight into the spatial regulation. 
2. Results  
2.1 Molecular cloning of a HpaBPS transcript from chitosan-treated roots 
Using a homology-based cloning strategy and the mRNA pool from 
roots treated for 2 days with chitosan, a full-length cDNA was cloned. 
The 1188 bp open reading frame (ORF), which was re-amplified using a 
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proof-reading polymerase, encoded a protein of 395 amino acids with a 
molecular mass of 43.19 kDa and an isoelectric point of 6.2. The 
deduced amino acid sequence shared 96% identity with a previously 
isolated but functionally unconfirmed H. perforatum cDNA encoding BPS 
(ABP49616.1). Furthermore, 96 and 94% identities were observed with 
BPSs from H. sampsonii (AFU52908; Huang et al., 2012) and H. 
androsaemum (Q8SAS8; Liu et al., 2003), respectively. Expression of the 
HpaBPS gene in roots was up-regulated by chitosan treatment, as studied 
by RT-PCR (Fig. 1). There was a basal transcript amount before 
elicitation, which was massively increased 48 h after the addition of 
chitosan. The level of 18S rRNA served as control for equal RNA 
template amounts. 
 
 
 
 
 
 
 
Figure 1. RT-PCR amplification of HpaBPS transcripts (1188 bp) and a 18S rRNA 
fragment (485 bp) before and after treatment of roots with chitosan.  
 
2.2 Functional Analysis and Characterization 
The coding sequence of the HpaBPS cDNA was heterologously 
expressed in Escherichia coli as N-terminally His6-tagged protein and 
isolated by affinity chromatography. SDS-PAGE analysis demonstrated a 
high degree of purity of the 43 kDa protein (Fig. 2).  
      0                  48 
Post-elicitation time (h) 
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Figure 2. SDS-PAGE analysis of recombinant HpaBPS after staining with Coomassie 
brilliant blue. Lane 1, total protein from BL21 (DE3) cells harboring the HpaBPS 
cDNA-containing plasmid after induction with IPTG for 8 h at 25 °C; lane 2, 
recombinant HpaBPS protein after isolation by Ni2+-chelating chromatography; lane 4, 
molecular mass markers 
 
The properties of the enzyme were studied. The preferred starter 
substrate was benzoyl-CoA and the enzymatic product was identified as 
2,4,6-trihydroxybenzophenone by liquid chromatography-UV 
spectroscopy (LC-UV) and liquid chromatography-mass spectrometry 
(LC-MS) in comparison to a sample of authentic reference compound. A 
small amount of byproduct, 6-phenyl-4-hydroxy-2-pyrone, was also 
observed. HpaBPS also accepted to lower extents 3-hydroxybenzoyl-
CoA and isovaleryl-CoA. Use of isobutyryl-CoA and butyryl-CoA 
resulted in the formation of relatively high amounts of the 
corresponding byproducts. 2- and 4-Hydroxybenzoyl-CoA, acetyl-CoA, 
and CoA esters of cinnamic acids were not accepted as starter molecules 
(Table 1). The pH optimum of HpaBPS was 6.5 and the temperature 
optimum was 35°C. Under the optimum conditions, the kinetic 
properties of HpaBPS were studied for the preferred starter substrate 
benzoyl-CoA. The Km value was 1.992 µM and the kcat value was 7.73 s-1, 
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resulting in a catalytic efficiency (kcat/Km) of 3,87 s-1 µM-1. The Km value 
for malonyl-CoA was 12.09. The catalytic efficiency of HpaBPS was 
similar to those of H. androsaemum and Garcinia mangostana BPSs (Liu et 
al., 2003; Huang et al., 2012).  
2.3 In situ hybridization of HpaBPS transcripts 
Digoxigenin-labeled sense and anti-sense probes were generated and 
used for in situ localization of HpaBPS transcripts in roots. No specific 
staining was observed when the sense probe was used for whole-mount 
in situ hybridization (Fig. 3 A,C). However, intensive staining of both the 
apical and the distal parts of roots was found upon use of the anti-sense 
probe (Fig. 3 B,D). In cross sections of roots, no specific labeling was 
detected after hybridization with the antisense probe (Fig. 4 A). In 
contrast, the 
sense probe localized high levels of HpaBPS transcripts in the elongation 
zone to the first layer of the cortical parenchyma (Fig. 4 B). In addition, 
lower transcript levels were found in the endodermis. A similar staining 
pattern was detected in cross sections of the meristamatic zone (Fig. 4 
C). The other cell layers of the cortex were devoid of specific label, as 
illustrated at higher magnification in Fig. 4 D. 
 
2.4 Immunofluorescence localization of HpaBPS protein 
Sections of field-grown roots were incubated with either anti-BPS 
IgG or pre-immune IgG. No specific fluorescence was observed in 
longitudinal and in cross sections that were incubated with pre-
immune IgG (Fig. 5 a,c). However, when longitudinal sections 
were incubated with anti-BPS IgG, the apical meristem, the outer 
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cortical cell layer, and the endodermis were strongly 
immunofluorescent (Fig. 5 b). The root cortex was relatively thin 
and consisted of only few cell layers. A similar distribution of 
fluorescence between the tissues was observed in cross sections 
(Fig. 5 d). The majority of cells of the first cortical layer and the 
endodermis immunofluoresced. The exodermis, the inner cortical 
layers, and the vascular cylinder were devoid of specific 
fluorescence. The labeling specificity was confirmed by recording 
the lambda signature.  
 
 
 
Table 1. Substrate specificity of HpaBPS based on [2-14C] incorporation 
Substrate Activity (%) 
          Product Byproduct 
Benzoyl-CoA 100a        4.5 
2-Hydroxybenzoyl-CoA 0 0    
3-Hydroxybenzoyl-CoA 43.5 2.3 
4-Hydroxybenzoyl-CoA 0     0 
Cinnamoyl-CoA 0 0 
4-Coumaroyl-CoA 0 0 
Acetyl-CoA 0 0 
Isobutyryl-CoA 46.4 25.2 
Isovaleryl-CoA 11.8 3.7 
Butyryl-CoA 36.8 100 
a Product formation from benzoyl-CoA and malonyl-CoA was set as 100%. 
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Figure 3. Whole-mount in situ hybridization on apical (A,B) and distal (C,D) regions of 
in vitro grown roots. Samples were treated with either anti-sense (A,C) or sense probes 
(B,D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Tissue-specific localization of HpaBPS transcripts in thin sections of roots. A, 
control section treated with sense probe; B, section from the elongation zone treated 
with anti-sense probe; C, section from the meristematic region treated with anti-sense 
probe; D, detail from C showing labeling in the first cortical parenchyma layer (Cp) and 
the endodermis (En).   
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Figure 5. Immunofluorescence localization of HpaBPS protein in roots of field-grown 
plants. a,b longitudinal sections incubated with pre-immune IgG (a) and anti-BPS-IgG 
(b); c,d cross-sections incubated with pre-immune IgG (c) and anti-BPS-IgG (d). ca, 
calyptra; co, cortex; en, endodermis; ex, exodermis; me, meristem; sr, side root; vc, 
vascular cylinder. 
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3. Discussion 
The present studies of the spatial regulation of BPS expression in roots 
of H. perforatum demonstrate cell-type specific biosynthesis of xanthones. 
The major site of xanthone formation is the first cortical cell layer, as 
consistently revealed by in situ hybridization of BPS transcripts and 
immunofluorescence localization of the BPS protein. The cortex of H. 
perforatum roots is relatively thin and consists of only a few layers of 
storage parenchyma cells (Ciccarelli et al., 2001; Maggi et al., 2004). 
Xanthones appear to function as both preformed defence compounds, 
so-called phytoanticipins, and pathogen-inducible phytoalexins (Franklin 
et al., 2009). As phytoanticipins, they protect the roots from 
underground predators and microbial pathogens. For this reason, it 
appears reasonable that xanthones are accumulated in the outer cortical 
cell layer, which is, beside the exodermis, the primary site of attack. The 
defensive role of xanthones and related compounds was demonstrated 
(Gronquist et al., 2001).   
As phytoalexins, xanthones defend against bacterial and fungal 
pathogens. In in vitro cultures, formation of xanthones is readily inducible 
by the addition of elicitors (Abd El-Mawla et al., 2001; Conceição et al., 
2006; ,Franklin et al., 2009; Tocci et al., 2010, 2011). The antimicrobial 
activity, especially the antifungal property, of xanthones has been 
demonstrated (Franklin et al., 2009; Tocci et al., 2012). However, little is 
known about changes in the spatial regulation of xanthone biosynthesis 
in roots after the addition of elicitors or the infection by fungi and other 
predators.  
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A minor site of xanthone formation is the endodermis. This cell layer, 
beside the pericycle, has also been implicated in the biosynthesis of 
tropane and pyrrolizidine alkaloids (De Luca and St Pierre, 2000; 
Facchini, 2001; Moll et al., 2002). This localization may be related to the 
translocation of products. The functional aspects of xanthone 
biosynthesis in endodermis cells remain to be clarified and the 
expression patterns of further genes involved in this biosynthetic 
pathway need to be studied. Translocation of intermediates has recently 
been proposed for hypericin biosynthesis in H. perforatum (Zobayed et al., 
2006).  
4. Materials and Methods 
Chemicals: All the CoA esters of cinnamic acids and benzoic acids, 
apart from benzoyl-CoA, were synthesized as described in the literature 
(Liu et al., 2003). Malonyl-CoA, acetyl-CoA, and benzoyl-CoA were 
purchased from Sigma-Aldrich (St Louis, MO, USA). 2,4,6-
Trihydroxybenzophenone was obtained from ICN (Meckenheim, 
Germany). 6-Phenyl-4-hydroxy-2H-pyran-2-one (benzoyldiacetic acid 
lactone) was purchased from Aurora Fine Chemicals (Graz, Austria). 
Plant materials: In vitro roots were obtained from callus of H. perforatum 
and cultured as described by Tocci et al. (2011) in half-strength 
Murashige and Skooge (MS; 1964) medium supplemented with 1 mg/L 
indole-3-butyric acid (IBA). Liquid cultures were established by 
inoculating 0.02 g dry weight (DW) of roots in 250 ml Erlenmeyer flasks 
containing 100 ml liquid MS. The flasks were shaken at 100 rpm at 25 ± 
1°C and maintained in the dark. BPS gene expression was stimulated by 
adding chitosan (medium molecular weight; Sigma-Aldrich, Milan, Italy) 
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at a final concentration of 200 mg/l, on day 8 of culture. Root samples 
were harvested by filtration after 11, 15, 18, and 23 days of culture and 
subjected to extraction for high-performance liquid chromatography 
(HPLC) analysis. For RNA extraction, roots were harvested by filtration 
after 48 h post-treatment. 
Cloning of HpaBPS cDNA: mRNA from 48 h chitosan-treated roots 
was extracted according to the protocol optimized by Jaakola et al. 
(2001) for flavoinoid-rich plant materials. BPS cDNA was amplified 
using mRNA from 48 h chitosan-treated roots by RT-PCR and PCR 
using primers designed according to the sequence of BPS from Hypericum 
calycinum: the forward primer was 5‟-
GCATGCTAGCATGGCCCCAGCAATGGAATA-3‟ and the reverse 
primer was 3‟-GCATGGTACCTCACTGGAGGATGGGGA-5‟. PCR 
was carried out using Taq DNA polymerase (Peqlab, Erlangen, 
Germany). After denaturation at 95°C (2 min), 30 cycles were performed 
at 95°C (30 sec), 64°C (30 sec), and 72°C (1 min). The final extension 
was at 72°C for 15 min. Nucleotide sequences were determined from 
both strands. 
Heterologous expression and enzyme purification: The ORF 
encoding HpaBPS was reamplified by PCR using Pfu DNA polymerase. 
The amplified DNA was cloned to pRSET B (Invitrogen, Carlsbad, CA, 
USA) with Nhe І/Kpn І site. After sequencing of the ORF on both 
strands, the recombinant plasmids were introduced into E. coli BL21-
CodonPlus (DE3)-RIL (Stratagene, Amsterdam, Netherlands) for 
overexpression as N-terminally His6-tagged protein. HpaBPS was 
purified to homogeneity using Ni-NTA agarose according to the 
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manufacturer‟s instructions (Qiagen, Hilden, Germany). The purification 
efficiency was monitored by SDS-PAGE.  
Enzyme assay and kinetic data determination: The standard assay 
(250 μl) contained 54 μM starter CoA, 324 μM malonyl-CoA, 0.1 M 
potassium phosphate (pH 7.0) and 2 μg protein. After incubation at 35 
°C for 10 min, the enzymatic products were extracted and detected as 
described previously (Liu et al., 2003). Kinetic constants were 
determined using eight substrate concentrations covering the range of 
0.2-12 Km, the concentration of the second substrate was saturated.  
Digoxigenin-labelled riboprobe synthesis and whole-mount in situ 
hybridization: Digoxigenin-labelled riboprobes against BPS were 
generated using the mirVana Probe Construction Kit (Ambion). The 
antisense probe (CCGAGCCAAACCCTTGGTCGGGAcctgtctc) was 
designed following the analysis of alignments. The sense probe from the 
same region was used as a negative control. Whole-mount in situ 
hybridization was performed according to the protocol by Hejátko et al. 
(2006) on in vitro cultured roots collected at day 8 of culture. Signals were 
detected with alkaline phosphatase-conjugated sheep antidigoxigenin 
antibody (1:2000; Roche). Colour detection was carried out by incubating 
roots with a mixture of NBT (0.15 mg/ml) and BCIP (0.075 mg/ml) 
(Roche) in complete darkness for 2–4 h and subsequent stopping in 
ethanol. Expression levels were defined by visual inspection. 
Embedding, sectioning, and microscopy: After hybridization, roots 
were embedded in Technovit 7100 (Kulzer GmbH, Germany) resin 
according to the manufacturer‟s instructions and cut in 10 µm sections 
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by using a microtome. Sections were imaged using a camera dhs 
MicroCam 5.0 attached to a Zeiss Axiostar plus Optical Microscope. 
Immunohistochemical Analysis: Using the resin technique, plant 
tissue was analyzed under a confocal laser scanning microscope. Root 
material was fixed on ice for 2 h under reduced pressure (vacuum 0.3 
mbar) in fixative solution (2% [w/v] formaldehyde, 0.1% [v/v] 
glutaraldehyde, 0.1% Triton X-100 [w/v] in 0.1 M phosphate buffer, pH 
7.2). The samples were washed twice for 10 min with PBS buffer. Water 
was gradually removed by 30, 50, 70, and 90% aqueous ethanol and 
finally 3 × 100% ethanol. Each step of incubation took 30 min at room 
temperature. After dehydration, the plant tissue was embedded in 
Technovit 7100 (Heraeus-Kulzer, Hanau, Germany) according to the 
manufacturer‟s instructions. Fixed tissues were cut into thin segments 
(3.5 μm) using a microtome (HM 355 S; Microm, Walldorf, Germany). 
The sections were transferred onto diagnostic microscope slides 
(Teflon®; Roth, Karlsruhe, Germany) using a drop of distilled water and 
left to dry. The thin sections were incubated in 50 mM ammonium 
chloride solution at 37°C for 15 min, washed with water, incubated in 50 
mM glycin solution at 37°C for 15 min and washed again with water. 
The sections were then blocked at 37°C for 30 min with BSA-blocking 
solution (10% [w/v] BSA and 0.1 % [w/v] fish gelatine in PBS buffer, 
pH 7.2), washed once with water and 3 × 10 min with PBS buffer. 
Thereafter, the sections were incubated with either anti-BIS IgG oder 
preimmune IgG (1:25 to1:100 dilution) with 1% BSA in PBS buffer at 
37°C for 1 h. They were washed once with water and 3 × 10 min with 
PBS buffer. Finally, the sections were incubated in the dark with 
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fluorescence dye-conjugated goat anti-rabbit antibody as secondary 
antibody (Alexa Fluor® 488 goat anti-rabbit IgG (H+L); Molecular 
Invitrogen, Darmstadt, Germany) diluted 1:100 with 1% [w/v] BSA in 
PBS buffer at 37°C for 1 h. After washing 3 × 15 min with PBS buffer 
and then with water, sections were left in the dark at 37°C until dryness. 
Mounting medium (Citifluor; Agar Scientific, Essex, UK) was used to 
adhere the coverslip to the tissue section. The tissues were viewed using 
a laser scanning microscope (Zeiss LSM 510META, Göttingen, 
Germany). The scan mode was channel scan. The imaging of whole-
mount specimens was recorded using a digital camera (Axioskop 2; 
Zeiss) and the software Axio Vision 3.0 (Zeiss). 
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H. perforatum is one of the most studied medicinal plants, but little is 
known about xanthone biosynthesis in the species.  
The main topic of the project has been the study of xanthone 
biosynthesis both  in planta and in in vitro systems of H. perforatum subsp. 
angustifolium (Hpa), a rare subspecies showing higher secondary 
metabolites production in comparison with other H. perforatum 
subspecies (Southwell and Campbell, 1991). The interest in xanthones 
relies in their documented biological activities (Fotie and Bohle, 2006), 
which find applications in solutions for human health. Particularly 
interesting is the antifungal activity exerted by these compounds in the 
light of the growing demand for antifungals as a consequence of the 
worldwide increased incidence of fungal infections and of the spread of 
multidrug-resistant strains of fungi.  
 
The present  investigation has been characterized by an approch of both 
basic and applied research and has been articulated in two main aspects 
deeply connected:  
1. Investigation of xanthone biosynthesis at histochemical, 
chemical and molecular levels both in planta and in in vitro systems. 
2. Development of root cultures as an in vitro system to produce 
xanthones and xanthone-rich and standardized extracts for 
applicative purposes in the field of antifungal therapy. 
The fungi selected in the present study were Candida spp., the main agent 
responsible for nosocomial fungal infections (Pfaller and Diekema 2010); 
C. neoformans, a common life-threatening human fungal pathogen; and 
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dermatophytes, which are responsible for fungal skin infections 
(Seebacher et al. 2008). 
Xanthone accumulation in planta 
In order to investigate xanthone distribution in wild grown Hpa plants, 
samples were collected in two sites nearby Rome (Italy) characterized by 
different altitude and soil composition: Tivoli Terme is  at 68 m above 
the sea level (asl) and is characterized by a calcareous soil; Poli is  at 453 
m asl and the soil is volcanic. The chemical analysis showed that 
xanthones are not distributed all over the plant, but their accumulation is 
confined to the roots. 1,7-dihydroxyxanthone, 5-O-methyl-
2deprenylrheediaxanthone B, kielcorin, paxanthone, 1,3,5,6-  
tetrahydroxyxanthone, and 1,3,6,7- tetrahydroxyxanthone were detected 
in Hpa. The xanthones 1,7-dihydroxyxanthone, 1,3,5,6-
tetrahydroxyxanthone and paxanthone were reported in this study for 
the first time for H. perforatum plants collected in field. Variability has 
been observed in the xanthone content of the roots collected in the two 
considered areas (0.43± 0.03 and 0.18±0.02 mg/g DW in Tivoli Terme 
and Poli, respectively). It is known that secondary metabolite content is a 
quantitative trait and that levels can be influenced by environment. 
Although the total xanthone amount is quite low, 1,7-
dihydroxyxanthone, and 1,3,5,6- and 1,3,6,7-tetrahydroxyxanthones are 
reported by other authors for antimicrobial activity (Fotie and Bohle, 
2006). In a study by Crockett el al. (2011), the extracts of roots of H. 
perforatum were tested for growth inhibition of plant pathogenic fungi of 
the genera Colletotrichum, Botrytis, Fusarium and Phomopsis, and 5-O-methyl-
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2-deprenylrheediaxanthone B was found to possess antifungal activity in 
particular against Phomopsis. 
In the present study the extract of Hpa roots collected in Tivoli Terme, 
which was the richest in xanthones, has been tested for the first time 
against a broad panel of human fungal pathogens and showed a 
moderate antifungal activity against dermathophytes and C. neoformans 
(geometric MIC mean 215.27 µg/ml and 53.8 µg/ml respectively) .  
Biomolecular studies of xanthone biosynthesis in planta 
In order to investigate xanthone biosynthesis in planta at a biomolecular 
level, the gene encoding for benzophenone synthase, the key enzyme in 
xanthone biosynthetic pathway, has been studied. Xanthones have been 
detected in H. perforatum plants (Crockett et al., 2011; Tocci et al., under 
revision), but nothing is known about the expression pattern of the 
genes involved in their production. Root cultures of Hpa have been 
shown to be an in vitro system in which the synthesis of xanthones can be 
regulated by external stimuli. Chitosan and its derivatives were found to 
be able to induce a massive accumulation of xanthones in in vitro cells 
and roots (Tocci et al., 2010; Tocci et al., under revision) suggesting a 
rapid induction of  xanthone-related gene expression. In the light of the 
above mentioned data, root cultures treated with chitosan have been 
studied for cloning and characterizing a full length BPS gene in order to 
generate a probe for the localization of the relative transcript expression 
in seedlings. The cloning work led to the obtainment of a 1188 bp ORF 
which encoding for a 43.19 kDa protein, which deduced aminoacid 
sequence showed 96% identity with BPS from H. perforatum and H. 
sampsonii and 94% with H. androsaemum trihydroxybenzophenone 
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synthase. The RT-PCR showed that the  expression of the studied 
cDNA in roots deeply increased after treatment with chitosan. The 
coding cDNA was heterologously expressed in E. coli and purified to 
assay the enzyme activity in vitro. The functional analysis confirm the 
identity of the protein as BPS. The substrate specificity assays showed 
that BPS accepted various substrates, but benzoyl-CoA was the preferred 
starter. 
The present studies of the spatial regulation of BPS expression in roots 
of H. perforatum demonstrate cell-type specific biosynthesis of xanthones. 
The major site of xanthone formation is the first cortical cell layer, as 
consistently revealed by in situ hybridization of BPS transcripts and 
immunofluorescence localization of the BPS protein. The cortex of H. 
perforatum roots is relatively thin and consists of only a few layers of 
storage parenchyma cells (Ciccarelli et al., 2001; Maggi et al., 2004). 
Xanthones appear to function as both preformed defence compounds, 
so-called phytoanticipins, and pathogen-inducible phytoalexins (Franklin 
et al., 2009). As phytoanticipins, they protect the roots from 
underground predators and microbial pathogens. For this reason, it 
appears reasonable that xanthones are accumulated in the outer cortical 
cell layer, which is, beside the exodermis, the primary site of attack. The 
defensive role of xanthones and related compounds have been 
demonstrated (Gronquist et al., 2001).   
As phytoalexins, xanthones defend against bacterial and fungal 
pathogens. In in vitro cultures, formation of xanthones is readily inducible 
by the addition of elicitors (Abd El-Mawla et al., 2001; Conceição et al., 
2006; Franklin et al., 2009; Tocci et al., 2010, 2011). The antimicrobial 
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activity, especially the antifungal property, of xanthones has been 
demonstrated (Franklin et al., 2009; Tocci et al., 2012). However, little is 
known about changes in the spatial regulation of xanthone biosynthesis 
in roots after the addition of elicitors or the infection by fungi and other 
predators.  
A minor site of xanthone formation is the endodermis. This cell layer, 
beside the pericycle, has also been implicated in the biosynthesis of 
tropane and pyrrolizidine alkaloids (De Luca and St Pierre, 2000; 
Facchini, 2001; Moll et al., 2002). This localization may be related to the 
translocation of products. The functional aspects of xanthone 
biosynthesis in endodermis cells remain to be clarified and the 
expression patterns of further genes involved in this biosynthetic 
pathway need to be studied. Translocation of intermediates has recently 
been proposed for hypericin biosynthesis in H. perforatum (Zobayed et al., 
2006). This is the first study of organ localization of bps expression in 
Hpa. Further studies are in progress to localize the cell-specific 
expression of BPS gene in thin sections of H. perforatum plant organ at 
different developmental stages and under elicitation treatments.   
Xanthone production in in vitro systems 
In vitro cultures are a good system to overcome the problems linked to 
the variability and the seasonal dependence of metabolite recovery from 
wild grown plants. Cell cultures of H. perforatum have been already 
established by many authors (Dias et al., 2000; Pasqua et al.,2003; Ferrari 
et al., 2005; Tocci et al., 2010), but the production of xanthones was not 
exploitable for applicative purposes.  
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In the present study, cultures of seedlings and in vitro regenerated roots 
have been established and for the first time evaluated for xanthone 
content.  
In comparison with the plants collected in field, chemical analysis 
showed that roots from in vitro plantlets were 27 folds richer in 
xanthones. Differently, from the roots of wild grown plants, roots of in 
vitro seedling contained toxyloxanthone B, yet they did not contain 
kielcorin.   
A comparison of antifungal activity against C. albicans, non albicans 
Candida species, C. neoformans, and dermatophytes of H. perforatum roots 
from wild grown plants and from plantlets grown under controlled 
conditions highlighted that the geometric mean MIC for the root 
extracts from the in vitro plantlets was 9 times lower for C. albicans and 
for the non-albicans Candida species, and 2 times lower for 
dermatophytes. In parallel it was shown that the extracts deriving from 
plantlet roots showed an improved antifungal activity in particular 
against Candida spp., highlighting a linear positive correlation between 
xanthone amount and bioactivity exerted. Although the extracts from 
roots of in vitro seedlings showed interesting antifungal activity, the entire 
process to get the extracts requires long time (seed germination, plantlets 
grown, obtainment of great biomass amount, processing of the biomass 
to separate roots and aerial parts by hand, exsiccation of the plant 
material, extraction). Moreover, the hardness of automation of the 
process, in particular to separate the aerial parts from the roots, makes 
hard the scale-up. 
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The large-scale cultivation of roots for producing important 
phytochemicals has been achieved for medicinal plants such as 
Nothapodytes foetida (Fulzele et al. 2002), Panax notoginseng (Gao et al. 
2005), and Echinacea purpurea (Wu et al. 2007). Although root cultures of 
H. perforatum have also been established by other authors (Cui et al. 2010; 
Goel et al. 2009), the capacity of these cultures to produce xanthones has 
never been explored. In the present work, cultures of in vitro regenerated 
Hpa roots have been shown to be a good alternative biotechnological 
system to produce xanthone-rich extracts. Culture conditions for root 
biomass increase and xanthone production have been optimized and our 
data indicated that a concentration of 1 mg l-1  IBA in the culture 
medium (Medium 1) was the most suitable to obtain not callused roots 
and high production of xanthones. The highest concentrations of IBA 
inhibited xanthone accumulation, confirming reports that high auxin 
levels are often deleterious to secondary metabolites in other species 
(Dornenburg and Knorr 1995; Chan et al. 2005). Cultured roots 
produced xanthones in large amounts and at higher concentration in 
comparison with roots from seedlings. Moreover the extracts showed a 
very stable trend of xanthone accumulation throughout the culture 
period. Elicitation treatments, revealed that xanthone accumulation can 
been stimulated by chitosan, a polymer that is able to influence 
biosynthesis of xanthones in cell cultures of Hpa (Tocci et al. 2010). 
Chitosan treatment resulted in a cessation in growth and a decrease in 
biomass. Moreover, the elicitation induced a high, even if transient, 
xanthone production with a peak of 14.26±0.627 mg/g DW after 7 days 
of treatment. Regarding the antifungal activity of the extracts, an 
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encouraging results was observed for all of the fungal strains tested: 
Candida spp., C. neoformans, and dermatophytes. This activity significantly 
increased when using chitosan, and high activity was found for extracts 
obtained after 7 days of treatment (mean MIC of 83.4 µg ml-1, 39.1 µg 
ml-1 and 114 µg ml-1 against, respectively, Candida spp, C. neoformans, and 
dermatophytes), confirming the positive linear correlation between 
xanthone content and antifungal activity. Xanthones therefore could be 
the principal constituents responsible for the antifungal activity.  
In the light of the reported observations, a further stimulation of 
xanthone production was induced by subculturing roots in a medium 
composed by a combination of growth regulators previously optimized 
for cell cultures of Hpa (Tocci et al., 2010). The medium contained 1-
naphthalenacetic acid (NAA), 2,4-dichlorophenoxyacetic acid (2,4-D) 
and kinetin (Medium 2). Previous studies have shown that NAA 
stimulated xanthone accumulation in cell suspension cultures of 
Hypericum perforatum (Dias et al., 2001; Tocci et al., 2010). The roots 
cultures in this conditions were able to produce 3.53 times higher 
xanthone production and  showed from 5 to 10 times higher antifungal 
activity against Candida spp., C. neoformans, and  dermatophytes, but the 
biomass growth was negatively affected.  
To combine the collected knowledge a three-step culture system was 
developed to optimize the culture conditions of in vitro roots in order to 
obtain the best xanthone production. The system consisted in a first step 
culturing roots in Medium 1 to obtain a consistent amount of root 
biomass; a second step of subculture in Medium 2 to increase secondary 
metabolite production and a third step with the addition of chitosan to 
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further stimulate xanthone production. The extracts obtained from roots 
cultured in Medium 2 and treated with chitosan were the richest in 
xanthones compared to the previous samples and showed an improved 
antifungal activity against all the tested strains of Candida spp., C. 
neoformans, and  dermatophytes.  
Chitosan has been shown to stimulate xanthone biosynthesis, but in 
spite of its advantages, the poor solubility, low surface area, and porosity 
are the major limiting factors in its utilization for applicative purposes. 
Chemical modifications of chitosan are increasingly studied for the 
potential of providing new applications. O-carboxymethylchitosan 
(CMC) is a water-soluble chitosan derivative, which has been widely 
studied because of ease synthesis, ampholytic character and possibilities 
of numerous applications and very low toxicity (Mourya et al., 2010, De 
Oliveira et al., 2012). CMC has shown to enhance chilling tolerance in 
cucumber seedlings (Sun et al., 2004) and storage protein accumulation 
in maize seeds (Osuji et al., 1992) and to delay powdery mildew desease 
in strawberry (Lowe et al., 2012). To our knowledge this is the first time 
that the CMC and its derivatives are used as elicitors of bioactive 
metabolites in H. perforatum. In all the analyzed treated samples it has 
been found that CMC derivatives stimulated the synthesis of xanthones. 
In comparison with the others, CMC- and N-benzyl-O-
carboxymethylchitosan (BzCMC)-treated roots were characterized by the 
higher amount of xanthones (26.4±2.13 and 9.08±0.16 mg/g DW 
respectively). CMC, in particular, induced the highest xanthone 
accumulation even in comparison with commercial chitosan. Extracts of 
CMC- and BzCMC-treated roots were tested for antifungal activity 
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against Candida species, dermatophytes and C. neoformans and  the best 
activity was found in all the assayed strains for CMC-treated roots. 
Bioassay-guided fractionation of extracts from roots treated with CMC 
led to the individuation of an fraction obtained by biomass extraction 
with ethylacetate and containing the higher amount of xanthones (6.8%). 
The fraction showed the best antifungal activity in comparison with the 
other tested ones. Ethylacetate fraction has been then subjected to 
chromatographic separation leading to the purification of a bioactive 
xanthone, the biyouxanthone D, a prenylated xanthone isolated by 
Tanaka et al. (2010) from roots of H. chinense and reported for the first 
time in the present paper for H. perforatum. This xanthone represented 
the 37.98% of the all detected xanthones in the total extract and the 
44.59 % of the ethylacetate fraction. The antifungal activity of 
biyouxanthone D, reported for the first time in the present work, 
showed a high activity against C. neoformans and dermatophytes. 
Moreover, in all the tested extracts, a linear positive correlation between 
antifungal activity and concentration of biyouxanthone D was evident, 
suggesting that biyouxanthone D is an active constituent of the H. 
perforatum regenerated roots, against dermatophytes and C. neoformans. 
Little information is available on mechanism of action of xanthones as 
antifungals, recently Pinto et al (2011) reported that oxygenated 
xanthones reduced the biosynthesis of ergosterol. Moreover, it is 
important to underline that biyouxanthone D is a  prenylated compound. 
It is known that the presence of isoprenoid chains is a major determinant 
of the bioactivity which resides in a enhanced interaction with biological 
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membranes and in an increased affinity for target proteins (Botta et al., 
2006).  
The present study represents a step forward in the preparation of 
formulations containing  H. perforatum root extracts for applicative uses 
in the developing of new antifungal agents.   
The process is actually under scale-up for the culture in bioreactor in 
collaboration with the ROOtec bioactives AG company in Witterswil, 
Swiss. 
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